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ABSTRACT
Mature mammalian CNS neurons do not regenerate or recover following
injuries. Different transcription factors have been linked to axonal growth and
survival, and regulation changes in these transcription factors will affect the
expression levels of genes involved in axonal regeneration. A robust collateral
sprouting response within the distant terminal field of magnocellular neurons, the
neurohypophysis, arising from the contralateral non-injured supraoptic neurons
have been shown in response to unilateral denervation of MCNs tracts. This
response peaked at age 35 days then it was followed by a complete loss of the
regenerative capacity between 35 days and 125 days of age. Our aim is to
compare the transcription profile between young regenerating neurons and
mature non-regenerating neurons and resident glia, the pituicytes, in the
neurohypophysis. The hypothalamic-neurohypophysis system was used to study
the epigenetic changes that underlie the decline in neuronal plasticity in the
context of dynamic neuronal-glial interaction. RNA-seq analysis and enrichment
analysis determined upregulated and downregulated genes with their functional
pathway enrichment.

x

CHAPTER I
INTRODUCTION
Hypothalamic-Neurohypophysial System
Studies of the Hypothalamic-Neurohypophysial System (HNS) has
served as a guiding role in our understanding of the communication between
the brain and peripheral physiology such as maintaining body fluid
homeostasis and regulating the reproductive system. The concept of
“neurosecretion” suggested by Ernst and Berta Scharrer in the 1920s was
faced by strong resistance from the scientific community at the time but the
idea of nerves secreting hormones had kept growing until it was fully
accepted in the 1950s (Sliverman et al. 1983) particularly when
George Gomori applied the Gomori trichrome stain used before in
the pancreas to stain the hypothalamus. Gomori successfully showed
neurons that act as hormone producing cells with projections that extends
toward the neurohypophysis (posterior pituitary or Neural lobe, NL). Technical
advances in the neuroscience field provided the definitive answer to the
anatomical, ultrastructural, and biochemical features of the HNS. The HNS
now plays a pivotal role in understanding many aspects of neurobiological
functions and it serves as a model system in neurobiology and
endocrinology. The HNS is composed of large neurons of the hypothalamic
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supraoptic and paraventricular nuclei that send their axons and terminals to
the neural lobe.
Hypothalamus
The hypothalamus is the portion of the diencephalon, a part of the
forebrain that lies below the thalamus, and directly above the pituitary gland
stalk (infundibulum). The anterior boundaries are the lamina terminalis and
anterior commissure, the posterior boundaries are the mamillary bodies and
midbrain. In a coronal section of the brain at the level of the optic chiasm, the
third ventricle makes up the core of the hypothalamus and many of the major
neuron cell groups are located near the midline. Major hypothalamic nuclei
that have great significance to the HNS are the paraventricular nuclei (PVN)
lateral to the third ventricle, supraoptic nuclei (SON) adjacent to the lateral
border of the optic chiasm and other accessory magnocellular cell groups, of
which the largest is the nucleus circularis located midway between SON and
PVN (Fisher et al. 1979). These nuclei were identified by injecting horseradish
peroxidase (HRP) in the neural lobe and 2-3 days after, the compound was
found accumulating in these nuclei (Sherlock et al. 1975). The paraventricular
nucleus is divided into two subdivisions; the medial subdivision is composed
of parvocellular neural cells with smaller cell bodies (10-15 µm cell body
diameter), whereas the lateral subdivision consists of large neurons
(20-40 µm), hence the name Magnocellular neurons (Burbach et al. 2001).
The SON cellular structure is composed of magnocellular neurons, microglial
cells, endothelial cells, and macroglia astrocytes.
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In the SON, the most ventral portion of the SON is called ventral glial
limitans (VGL) that lies ventral to the dendritic zone formed by MCNs
(magnocellular neurons) axons. The distal dendrites of all SON neurons run in
the ventral glial lamina (VGL), allowing the contact between afferent input that
enters the dendritic zone with fine dendrites coning from MCNs (Hatton
G.1990). Astrocytes in the VGL show a reorientation from vertical to
horizontal, during SON activation, where VGL shows thinning to
accommodate the change in MCNs (magnocellular neurons) volume (Salm
and Hawrylak. 2004).

Figure 1. Diagram of rat brain at the level of supraoptic (SON) and
paraventricular (PVN) nuclei. The diagram shows the location of two major
nuclei with SON lying adjacent to optic chiasm (OC), PVN adjacent to the
third ventricle. Axons(yellow) extending from magnocellular neurons (MCNs)
in the hypothalamic nuclei down passing through the median eminence
toward their terminal field in the neural lobe. 3rd V: third ventricle. (Hatton GI.
2004)
3

Cellular components of HNS
Magnocellular neurons (MCNs)
Magnocellular neurons (MNC, also called peptidergic neurons) are
the primary neurons in the HNS. The SON (supraoptic nucleus) contains
only MNCs, which synthesize either oxytocin or vasopressin. In contrast,
the PVN (paraventricular nucleus) also contains parvocellular neurons that
project to the Zona externa of median eminence as well as to other brain
regions (Sofroniew MV, 1983). Immunohistochemical studies have shown that
most of the magnocellular neurons are rounded or oval. Most MCNs have
between one and three dendrites (Stern and Armstrong. 1998). Most cells are
multipolar, although the dendritic harbor does not extend
extensively (Silverman and Zimmerman, 1983).
There are two main types of magnocellular neurons, each named
after the main neuropeptide they release: Oxytocin neurons (OT) and
Vasopressin neurons (VP). OT and VP MCNs are found intermingled in the
magnocellular nuclei, although there is some topographical segregation
(Burbach et al. 2001).
Within the SON, OT neurons are located dorsal and rostral, whereas
VP neurons are located ventral and caudal. The beaded axons leave the SON
dorsomedially then turn caudally and pass through the dorsal portion of the
internal layer, the zona interna, of the median eminence (ME) and form the
entirety of the pituitary stalk before branching profusely throughout
the neural lobe (Alonso et al. 1981). In addition, radiographic studies in rat
showed that labeled axonal bundles were found to project into various
4

extrahypothalamic regions, including the olfactory bulb, the cortex, the lateral
habenula, the sub commissural organ, the amygdala, the mammillary
bodies, and the locus coeruleus (Alonso et al.1981). Studies on the afferent
input to the SON showed that the distal dendrites of all SON neurons run in
the ventral glial lamina, such that any input that enters the dendritic
zone can encounter finer processes of either types of MCNs, whereas the
cortically projecting dendrite appear to be situated to receive input from
olfactory and vomeronasal system afferents (Hatton.1990).
Astrocytes
Astrocytes are specialized glial cells that outnumber neurons by
over fivefold (Sofroniew et al. 2010). According to their morphology and
location, astrocytes can be divided into two groups: protoplasmic type of the
grey matter which envelopes neuronal bodies and synapses and fibrous type
of the white matter that contact Node of Ranvier and oligodendrocytes. Unlike
neurons, expression of glial fibrillary acid protein (GFAP) has become
a biological marker for astrocytes in immunohistochemical studies (Salm and
Hawrylak. 2004).
The well-developed protoplasmic astrocytes contain numerous
processes forming well-delineated bushy territories, with up to 80% of the cell
membrane forming fine processes with high surface area to volume ratios.
These processes contact synapses, blood vessels, and other glial cells
(Zhou et al. 2019). This fine structure of astrocytes processes infiltrating the
space in between neurons is found to be highly plastic and activity dependent.
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Astrocyte Functions
Over the years, it has become clear that astrocytes provide more than
supportive functions for neurons. Their function begins with CNS development
when growing neurites can be directed to their targets by astrocyte-derived
guidance molecules independent of effects on process extension. These
molecules include astrocyte tenascin-C and proteoglycans that are distinct
components of astrocyte boundaries (Powell and Geller. 1999). There is
a substantial amount of evidence that supports the role of astrocytes in
developing synapses. A study done by (Christopherson et al .2005) reported
that Thrombospondins TSP-1 and –2 expressed by immature astrocytes
act as a permissive switch that times CNS synaptogenesis by enabling
neuronal molecules to assemble into synapses within a specific window of
CNS development. Astrocytes also release proteins that promote neuronal
survival and induce neuron growth and differentiation. Among these
proteins are the ciliary neurotrophic factor (CNTF) and basic fibroblast growth
factor (bFGF) (Vaca and Wendt. 1992).
Cerebral blood flow regulation happens at the basal level and in
response to brain activity (MacVicar and Newman. 2015). Studies have
shown that astrocyte processes have end feet structure that contact blood
vessels and can contribute to the cerebral blood flow regulation through the
mechanism of neurovascular coupling mediated by astrocytes. One of the
mechanisms is mediated through phospholipase A2 -arachidonic acid (AA)
pathway activation that is associated with high intracellular astrocyte end
foot level of Ca2+, leading to vasoconstriction in cerebro-vasculature and
contributing to the brain blood flow (Mulligan and MacVicar. 2004).
6

Whereas, in a low O2 situation, glycolysis is enhanced and extracellular levels
of lactate increase, leading to higher extracellular prostaglandins PGE2 and
enhanced relaxation of smooth muscle tone and vasodilation (MacVicar and
Newman. 2015).
The Blood Brain Barrier (BBB) is a specialized vascular component
that regulates the CNS homeostasis. It primarily consists of endothelial cells
surrounded by perivascular astrocytes end feet with pericytes embedded in
between. Interaction between these cells and endothelial cells through tight
junctions contribute to the unique metabolic and physiological function of the
BBB that renders it a dynamic interface (Liu et al. 2012). Astrocytes release
several factors that are crucial for maintaining BBB integrity and function,
among these factors are: angiogenic factors that promote vascular growth
such as vascular endothelial growth factor (VEGF), angiopoietins (Ang-1, 2, 3,
and 4) and Src suppressed C kinase substrate (SSeCKS) that regulate
angiogenesis (Alvarez et al. 2013).
Like neurons, astrocyte communicate with each other via gap
junctions. These junctions utilize a gap junction protein expressed by
astrocytes, among these subunits are Connexin 43 (Theis et al. 2005). These
communications maintain an effective and well-organized responses among
the astrocyte's community.
Astrocyte processes are involved in all synapses, they are crucial
for maintaining a healthy synaptic environment, and that includes fluid pH,
ions, and transmitters level such as glutamate, GABA (gamma aminobutyric
acid), and glycine. The glial water channel aquaporin-4 (AQP4) has been
7

shown to regulate the extracellular fluid and fluids inside the astrocytes (Zador
et al. 2009). Overwhelming evidence implicates astrocytes as a key player in
pH homeostasis in the brain. Among the membrane proteins involved in
proton shuttling are the Na+/H+ exchanger, different classes of bicarbonate
transporters, monocarboxylic acid transporters and the vacuolar-type
proton ATPase (Obara et al. 2008). Regulation of pH in the brain is a twoway street, wherein alterations of pH, triggered during brain activity, can
also modulate the astrocyte glucose utilization and glutamate formation
(Brookes. 2000).
Another key function of astrocytes in the brain is their ability to remove
neurotransmitters from synapses. For example, glutamate reuptake occurs
through two glial specific transporters excitatory amino acid transporter 1
(EAAT1) and (EAAT2), several reports suggested that astrocytes also release
neuroactive agents including the neurotransmitters glutamate, ATP, and
serine. However, the function and the mechanism of such release is still
not clear (Seifert et al. 2006).
Macroglial cells, although non-excitable, express a wealth of voltageactivated ion channels that are typically characteristic of excitable cells. They
can express several types of K+ channels, such as calcium and voltagedependent K+ channels (Sontheimer. 1994). However, the principal K+
channels found in astrocytes are the inwardly rectifying K+ (Kir) channels,
which allow K+ ions to flow much more readily in the inward than outward
direction, enhancing the K+ clearance rate. These channels are found
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colocalized with the (AQP4) water channels suggesting a coupled water
and K+ uptake in astrocytes (Kofuji and Neuman. 2004).
Astrocytes are organized in a tile-like manner enabling one astrocyte
contact with more than 100,000 synapses (Bushong et al. 2002). Considering
the close localization with neuronal synapses, astrocytes are expected to
have a direct effect, not only on synaptogenesis during initial stages of
development but also providing a regulatory signal that modulate presynaptic
function and postsynaptic recruitment of receptors of a mature neural circuit
as well as the structural synaptic formation through the release of different
molecules. Some of these factors that promote the synaptic function include
TGF-β (Transforming Growth factor -β), Cholesterol, ADNF (activitydependent neurotrophic factor) while others have negative effects on synaptic
function, such as SPARC (secreted protein acidic, rich in cysteine) (Chung et
al. 2015).
Glycogen is a fuel source that primarily exists in liver and muscles, but
it also exists in the brain at lower concentration, where it is predominantly
found in astrocytes. Astrocyte glycogen metabolism is affected by the release
of neurotransmitters and glucose levels, wherein it breaks down to lactate that
can be used as a fuel source by adjacent neurons (Brown A and Ransom B.
2007). An overwhelming amount of evidence demonstrated that astrocytic
glycogen utilization can maintain neuronal activity during hypoglycemia and
during periods of intense neuronal activity. Glucose and other metabolites are
found to traffic between astrocytes through gap-junction subunit proteins
connexin 43 and 30 (Rouach N, et al. 2008). Therefore, astrocytes provide a
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metabolic pool that has significant support during intense periods of
activation.
Neurohypophysis
The neurohypophysis occupies the posterior aspect of the pituitary
gland that sits in a depression in the sphenoid bone. The three parts of the
neurohypophysis are the infundibulum and median eminence (known as
Pars Proximalis), and neural lobe (known as Pars distalis) with infundibular
stem connecting them (Bargmann.1968). It consists of axonal projection from
magnocellular neurons that project down to reach the pituitary portal
circulation surrounding the neural lobe. A closer look at the structural
components of the neural lobe shows that the neural lobe is devoid of
neuronal nuclei and there are three main components: (1) glial components, a
specialized resident type of astrocytes known as pituicytes that occupies most
of the nucleated element. The pituicytes occupy approximately 30% of neural
lobe volume and a higher percentage of the total basal lamina volume under
basic physiological conditions (Hatton. 2009). (2) the perivascular
components, and (3) the neural elements which are mostly neurosecretory
axon terminals (filled with macrovesicles and neurosecretory granules),
additionally, there are detectable amounts of GABAergic, dopaminergic, and
noradrenergic axons that innervate the neural lobe. However, the bulk of
neural elements in the neural lobe belong to MCNs axons projecting from
SON and PVN (Hatton G, 1997). The axonal branches and terminals have
been estimated to represent approximately 50% of total tissue mass of the
neurohypophysis (Burbach et al. 2001). Neurosecretory terminals are
usually located at or near the basal lamina but separated from the lamina by
10

finger-like processes of pituicytes. The basal lamina is the barrier that
separates the neural lobe parenchyma from the perivascular space that
surrounds the fenestrated blood capillaries of the neural lobe. Microglia and
perivascular cells are found on the capillary side of the basal lamina
(Hatton.1997).

Figure 2. NL ultrastructural components under activated conditions. Electron
micrograph (left) of NL parenchyma showing densely packed neurosecretory
axons (ax) filled with neurosecretory vesicles interspersed with pituicytes thin
processes (Ast P arrowheads). Large dense black circles are lipid bodies (L)
indicating pituicytes, PVS perivascular space, basal lamina(arrowhead),
emptied axon terminal near the basal lamina (at). ECS: extracellular space,
Nu: pituicyte nucleus (Hatton. 2009). A diagram showing the typical
ultrastructure of inactivated NL (right), basal lamina (BL) separates the NL
parenchyma from perivascular area where fenestrated blood capillaries (fc)
are located. Pituicytes processes not only engulf axon terminals but also
separate them from basal lamina during low hormone demand. Arrows point
at axon terminal containing neurofilaments and lacking neurosecretory
vesicles (Watt et al.1999).
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Ultrastructural studies of human neurohypophysis showed that there
are five different classes of pituicytes; the major pituicytes that are considered
reminiscent astrocytes, oncocytic pituicytes, dark pituicytes, ependymal
pituicytes and granular pituicytes, the latter suggests an active uptake and
metabolism of extracellular components through phagocytosis (Takei et
al.1980). Clusters of vasopressinergic fibers are present within the central
region of the neural lobe, clusters of oxytocinergic fibers run in the peripheral
part (Van Leeuwen et al. 1979). Studies have also shown that axons of
magnocellular neurons have beaded appearance once they leave the cell
body and these swelling becomes larger as they enter the neural lobe, these
intermittent swelling contains large dense core vesicles, as well as other
organelles, such as: mitochondria, vacuoles, lysosomes, and other secretory
vesicles (Hatton. 1990). Thin section and freeze-tech electron microscope
enabled the studies on ultrastructural interface between pituicytes and axons
terminals in the neurohypophysis. These studies confirmed the presence of
sinusoid spaces (enlarged extracellular within the perivascular area) between
pituicytes and confirmed that this sinusoid space is sealed off from the
general extracellular space through different specialized types of junctions,
including but not limited to gap junctions and tight junctions (zonulae
occludentes). Gap junctions appear like densely packed particles
(8-9 nm diameter) mostly in hexagonal arrangements, they connect two
plasma membrane leaflets with extracellular space In between. These
junctions provide pituicytes coupling and suggest that these cells act as a
syncytium within the neural lobe. Gap junctions are sometimes found in
combination with tight junctions that appear like branching ridges under the
12

light microscope (Dreifuss et al.1975). These studies also showed the
detailed ultrastructural components of the pituicytes interface with neuronal
elements, wherein the finger like processes of pituicytes are protruding to
occupy the space. Pituicytes are featured by the presence of lipid droplets
and macrovesicles surrounding axon terminals, ribosomes and other
organelles depending on processes closeness to the cell bodies.
Neurosecretory axons engulfed by pituicytes processes seem to have access
to these sinusoid spaces. The close association between these different
components suggests that the neurohypophysis does not only provide
structural support but has a role in regulating the hormonal release in the
neurohypophysis suggested by the temporal and spatial changes in the
axonal neurosecretory granules as a response to salt loading and water
deprivation. In vitro and in vivo RNA labelling studies showed that pituicytes
hypertrophy and multiply during neural lobe stimulation, these stimulations
also increased the amount of lipid droplet and the RNA and protein
metabolism of pituicytes shown by the primary localization of labels in the
pituicytes nuclear region in autoradiographic studies (Sunde et al.1972)
(Salm et al. 1982).
HNS Plasticity
It has been long believed that adult brain structure is fixed once it has
completed development. Over years, however, an important feature of the
HNS morphological plasticity has become apparent. The HNS system retains
the ability to undergo structural remodeling of synapses and glial-neuronal
membrane contacts. Quantitative ultrastructural studies of SON show that
13

the amount of direct soma-somatic contact between neurosecretory neurons
in SON and glial processes following dehydration increases, apparently by
retraction of fine glial processes from between the cells, and the changes
were reversed following rehydration. The number of small and large
neurosecretory granules dropped as well and returned to normal levels by
24 hours of rehydration, indicating the morphological changes took place in
response to changes in hydration states (Tweedle and Hatton. 1977). A study
that investigated the extent of morphological changes in the dendritic
zone of the SON showed that direct membrane apposition and dendritic
bundles, where two or three dendrites bundle together leaving a small cleft in
between the membranes, increases consistently with increased hormonal
demand. Higher levels of K+ ions in the cleft in the absence of glia that usually
buffer the ions could impact the excitability of the neurons and contribute to
the synchronization of the MCNs firing patterns. Double synapses occur in the
ventral glial lamina/dendritic zone of the supraoptic nucleus and vary with
different physiological conditions (particularly during distinct stages of
parturition) and were found to correspond with oxytocin and vasopressin
hormone release. Glial retraction can allow for the conventional synapses
(with one presynaptic contacting one post synaptic membrane) to contact
more post synaptic membrane to form the double synapses (Perlmutter et al.
1984). Dendritic zone response to both chronic and acute dehydration and
rehydration was investigated as well. The response to acute deprivation was
both dose-dependent and reversible unlike chronic stimulation of SON
that resulted in even more dendro-dendritic contact, however, the nucleus
failed to return to the pre-stimulation configuration after chronic stimulation.
14

An examination of the posterior pituitary showed an apparent return
to normality (Perlmutter et al. 1985). The time scale of these changes can
range from minutes to hours and has been seen in other hypothalamic
systems and other CNS areas where neurons and astrocytes are in contact.
The HNS system responsiveness to different stimuli is reversible and these
stimuli are various including parturition, changes in blood pressure, cellular
dehydration/rehydration, extracellular fluid level changes, breast feeding,
mating behaviors and certain types of stress, where the reversal of the
conditions that triggered those changes will reset the system to its basal
level (Hatton. 1997). The astrocytic plasticity includes both morphological and
functional plasticity. Morphological plasticity involves a reactive gliosis
followed by glial retraction. It relates to the capacity of astrocytes to buffer
changes in extracellular K+ and glutamate, as well as the integrity of the
blood-brain barrier (BBB). The latter involves the expression and activity of a
series of ion and water transport proteins (Wang and Parpura. 2016). Levels
of glial fibrillary associated protein (GFAP), a cytoskeleton element in
astrocytes, changes in concert with changes in OT neuronal activity during
suckling. These changes occur periodically, accompanied by rhythmic
changes in glutamate metabolism, water transport, gliotransmitter release,
and spatial relationships between astrocytes and OT neuron (Wang and
Hamilton. 2009).
Wang and Hatton investigated the dynamic contribution of GFAP to
astrocytic plasticity. They showed that increased OT level following suckling
reduced the level of GFAP due to fragmentation and depolymerization and
this was followed by glial processes retraction. GFAP was found to be co15

expressed with Aquaporin 4 (AQP4), a binding partner of GFAP. These AQP4
molecule are coupled with inward K+ channels. During retraction, these
molecules are removed from the surface, preventing astrocytes from
buffering K+ leading to astrocytic shrinkage reflects on GFAP polymerization and
organization. Transient swelling of astrocytes following milk ejection response
promotes GFAP reorganization (Wang and Hatton. 2009). Other
functional consequences of glial process retraction are reduced level of
inhibitory molecules released by astrocytes such as the amino acid taurine
and increased levels of an excitatory glutamate. All these changes contribute
and facilitate an auto-stimulatory effect in the MCNs and seems to enhance
the excitability of these neurons to release their hormones (Hatton.1997). In
the neural lobe, the nature of neurovascular contact between the
neurosecretory terminals and the basal lamina which serve as peptide
diffusion barrier had led to the discovery of neural lobe plasticity under
lactation and hydration /dehydration conditions. These observations indicate
an inhibitory role of pituicytes occurs through the engulfing of the neural
lobe axons leading to fewer neurosecretory terminals abutting the basal
lamina (Hatton. 1997).
To summarize, the HNS system is not a fixed system as components
of the system change in response to neuronal activity, physiological cues, and
developmental changes. These changes include synaptogenesis, glialneuronal membrane apposition, dendrites length and their relationship to
other neurons, electrophysiological responses to stimuli, and cellular
orientation of neurons and pituicytes in relation to perivascular components of
the system.
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HNS as Model System
The HNS has impacted the understanding of excitation induced
secretion of neuropeptides, neuro-glial interaction and function associated
morphological plasticity. The reasons behind this significant impact pertain to
the clear topographic separation of the somatic and dendritic zone from the
axon terminals, the distinguished spatial and temporal orientation of the
astrocytes processes in-between neuronal cells that is suitable for observing
glial cells interaction with the MCNs, in addition to co-expression of
neuropeptides and other non-neuropeptides that contribute to the complexity
of autoregulation activity in the brain. The collateral sprouting response that
occurs at a distance from NHS lesion allows the examination of the process
without direct interference from the accompanying inflammatory process
associated with neural injury. Therefore, the SON remains a "model system"
in pursuing neuroscience research (Hou. 2016). There are striking similarities
between the HNS among varied species, but the rat model has provided the
most data on the HNS system (Hatton. 1990). MRI (Magnetic Resonance
Imaging) imaging in patients following hypophysectomy confirmed the in vivo
process of regeneration of what was called a “miniature posterior lobe” that
was previously seen in animal experiments (el Gammal et al. 1988). The rat
HNS anatomy is simple, well understood, and easy to distinguish cell bodies
and track neuronal trajectories. Therefore, the rat model was chosen for this
study.
In conclusion, The HNS is an attractive model to study mammalian
brain plasticity for the following reasons. 1) The anatomical components of the
system can be easily identified in terms of their location. Large neuronal cell
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bodies identifiable ultrastructural entities in the neural lobe. 2) The welldefined and robust responsiveness of the system to certain physiological
stimuli and ability to track the changes in hormonal release, which reflects the
system activation status accordingly, without the need to use electrical
stimulation. 3) The changes are observed uniformly in all components of the
system and are not limited to the neurons but involve the neurohypophysis as
well.
The regenerative responses following dissection of magnocellular
axonal tracts have been investigated in different situations and these studies
have shown that axons show sprouting evidence in the proximal end of
transected infundibulum and median eminence. In a study that used a
unilateral hypothalamic knife cut technique to severe the neurohypophysial
tract and denervate the rat neural lobe (NL), Watt and Paden (Watt and
Paden. 1991) showed an initial decline in the number of axons in the NL at
day 10 post-surgery (PS). Axonal degeneration is accompanied by
phagocytotic activity in the perivascular cells in the NL at day 5 post-surgery;
the decline in the number of axons was reversed by 30 days and sustained
for 90 days post lesion (about 3 months) without being accompanied by any
lesion- induced functional deficit in vasopressin secretion. These changes
are the result of collateral sprouting by the intact magnocellular efferent from
contralateral SON and/or PVN. These results were supported by the reduced
vasopressin immunoreactivity and size of NL. Other ultrastructural changes
coincided in the SON such as hypertrophy of the magnocellular neurons and
their nuclei in the contralateral SON/ PVN, along with the transient changes in
the NL total areas occupied by axons, pituicytes and extracellular space. The
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undergoing collateral sprouting of the uninjured MNS neurons along with
increased urine osmolality and decreased water intake suggest an increase in
neurosecretory activity, but the question that remained unanswered was
whether the sprouting was dependent on the neuronal activity or not.
In another study (Watt et al. 1999) gave the first direct demonstration
of the direct association between collateral sprouting by intact magnocellular
neurons and increased neuronal activity; this conclusion was supported
by neuronal and nuclear hypertrophy, increased OT and VAP mRNA pool,
and axonal cytochrome oxidase activity (COX) during period of neuronal
activation that coincided with robust increase in collateral sprouting between
1 and 4 weeks after the hypothalamic lesion. However, OT and VP mRNA
pool and COX activity along with the sprouting events were abolished during
chronic neuronal inhibition. The ability of chronic hyponatremia to block
the lesion induced sprouting of OT neurons noticed in the zona externa of the
median eminence 6 weeks after lesioning the PVN (Dohanics. 1994).
Exogenous CNTF was shown to promote the survival of MCNs axons
PVN explant cultures (Vutskits. 1998) but little was known about CNTF’s role
in promoting survival of MCNs in vivo. Therefore, in situ hybridization and
immunocytochemistry were utilized to identify the localization of CNTF in the
SON, PVN and neural lobe. In intact rat brain, CNTF was found exclusively in
the astrocytes within the VGL region of SON, but not in the PVN, and the
constitutive levels of the CNTF in the NL were rare. However, following
unilateral lesion of the neurohypophysial tract the CNTF immunoreactivity
started to rise in the axotomized SON, the intact contralateral SON
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following unilateral SON axotomy, and the NL. This response was
accompanied by increased CNTF mRNA levels in the axotomized SON,
suggesting that levels of CNTF are upregulated in response to both direct
injury and increased metabolic activity in sprouting MCNs (Watt et al. 2006).
To investigate the source of the CNTF expression in the NL, different
antibodies were used to study the colocalization of CNTF with other cellular
markers such as perivascular cells, pituicytes and microglial cells during
axonal degeneration and collateral sprouting response following partial
denervation of neurohypophysis in rat NL. CNTF was found to reach a peak
at day 10 post lesion, and it was localized in a phenotypically distinct
population of perivascular cells (P75LNGFRpositive/ OX-42 negative cells),
although both perivascular cells and parenchymal microglial cells showed
increased phagocytes as evidenced by increased lysosome surface marker
ED-1. Pituicytes have shown no colocalization of ED-1 marker with S100β
(calcium binding peptide), indicating that they are not involved in the
clearance of axonal debris under these conditions (Lo et al. 2008)
Immunocytochemistry and in situ-hybridization were utilized to study
the localization of ciliary neurotrophic factor receptor (CNTFRα) in the rat
brain. CNTFRα localizations were observed in the oxytocinergic and
vasopressinergic magnocellular neurons in the SON and the astrocytes within
the ventral glial limitans (VGL). Increased expression of CNTFRα mRNA was
observed near the neuronal somata in the SON contralateral to the lesion, but
not in the axotomized MCNs, which is indicative of neurotrophic effect of
CNTF on the MCNs (Watt et al. 2009).
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Expression levels of CNTF and the components of CNTF receptor
complex were examined using western blot studies in sprouting and
osmotically stimulated SON. These studies showed that CNTF levels as well
as CNTFRα and gp130 protein levels increased 10 days post lesion in the
sprouting SON. On the other hand, osmotically stimulated SON showed a
significant decrease in CNTF levels with no changes in the levels of CNTF
receptor components. Immunocytochemistry studies revealed a localization of
LIFRβ (Leukemia inhibiting factor receptor β), another CNTF receptor
complex component, in the SON astrocytes. In conclusion, the increase in
CNTF and CNTFR receptor components observed during the sprouting
response is a result of the sprouting itself, not the increased neurosecretory
activity. Furthermore, the localization of LIFRβ in the astrocytes support the
hypothesis that CNTF’s effect on MCNs axonal sprouting is mediated through
astrocytes (Askvig et al. 2012).
Regeneration Associated Genes (RAGS)
In the CNS, axonal injury results in limited regenerative capacity
compared to the peripheral nervous system (PNS), which can be contributed
to the neurons lacking the regenerative intrinsic properties and the nonpermissive glial environment in the CNS (Figure 3). CNS lesions convey
inhibitory non-permissive signaling pathways that interfere with epigenetic
regulation of regeneration associated genes (RAGs). These epigenetic
regulations include post translational histone modifications such as
acetylation by histone acetyl transferases (HATs) of lysine residues of H3 or
H4 leading to a more relaxed chromatin at gene promoter sites resulting in
upregulation of that gene. In addition, histone deacetylation by histone
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deacetylases (HDACs) result in gene downregulation when they form a
complex at the gene promoter. DNA methylation is carried out by DNA
methyl transferases such as DNMT3a/DNMT3b that initiate the de novo
methylation during development and DNMT1 that maintains methylation
afterwards. The binding of methyl binding proteins (MBP) to the methylated
cytosine initiates a series of events such as: HDACs / HKMTs complex
formation leading to different patterns of histone modification or “Histone
Code” that consequently will affect both global and gene specific changes and
chromatin accessibility changes. This code may also contribute to a specific
form of cellular memory that is maintained through generations (Lindner et al.
2013). Therefore, it is plausible to think that axonal regeneration program is
regulated by specific epigenetic changes that influence the accessibility
to genes associated with axonal regeneration and neuronal survival and the
rate of their expression.
The RAG program includes several hundred genes that are linked to
axonal regeneration, and they are differentially regulated following peripheral
axonal injury. The expression of these genes is regulated by a specific set of
transcription factors (TFs) that cooperate to initiate a RAG response that
eventually can induce long distance axonal regeneration. Viral vectormediated gene transfer is a powerful in vivo strategy that has been proved to
manipulate gene expression of RAGs through manipulating TFs, a tool that
can be used to validate the association of certain TFs with RAG
gene activation (Fagoe et al. 2014). As previously demonstrated, CNTF has
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Figure 3. Diagram summarizing the epigenetic pathways in CNS (nonpermissive) vs PNS (permissive). This model shows that CNS lesion will likely
convey an inhibitory downstream signaling (left-red) that does not allow for
axonal regeneration and growth cone formation, unlike PNS lesion (rightgreen), which will likely promote regenerative genes expression (purple oval)
to enable axonal regeneration and neuronal survival (Lindner et al. 2013)

been shown to promote axonal sprouting and neuronal survival of
magnocellular neurons. However, the mechanism by which CNTF promote
these functions was not clear. Therefore, organotypic cultures were utilized to
investigate the different signaling pathways involved in these responses. The
astrocytic JAK-STAT signaling pathway is necessary for mediating CNTF
induced OT neuronal survival (Askvig et al. 2013). The PI3K –AKT pathway
mediates the CNTF induced OT processes outgrowth in the SON. The MAPKERK1/2 pathway mediates the CNTF induced neuronal survival. Furthermore,
p38, JNK-MAPK, mTOR and NF-Kβ pathway promotes the magnocellular
neuronal survival in the absence of CNTF after axotomy. Taken together,
distinct intracellular pathways mediate different CNTF-mediated
neuroprotective processes (Askvig et al. 2015).
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The fact that regeneration in PNS succeeds in certain conditions but
fails in the CNS gives an idea of the impact of glial environment on the
inhibition of a full regeneration program in the CNS. Thus, it can be concluded
that the PNS environment is permissive unlike the CNS environment which is
thought to be inhibitory (Fawcett. 2019). Studies on the dorsal root ganglion
(DRG) brought to light the impact of the glial environment on the intrinsic
neuronal properties, a phenomenon known as “conditioning lesions “, a
condition where peripheral axotomy of these neurons not only activated the
peripheral branch axon regeneration but also the central branch that lies in
the CNS, a process that is associated with changes in gene expression and
epigenetic mechanisms that included global enrichment of histone H3 and H4
acetylation and DNA methylation /demethylation changes as well as the
chromatin accessibility (Wahane et al. 2019).
An overwhelming amount of research on CNS regeneration is starting
to shift toward the impact of intrinsic regeneration properties of neurons and
their axons. At the molecular level, studies have shown that the activation of a
subset of pro-regeneration associated genes including Gap43, Jun, sprr1a,
Gal, Bdnf, Rab13, arginase1 and others are associated with axonal
regeneration in PNS injuries (Lindner et al. 2013).
Axonal injury triggers signaling cascades that includes different
pathways and downstream transcription factors that could impact the
regeneration associated genes expression in different ways and contribute to
certain outcomes. We believe that the changes in the epigenetic mechanisms
that regulate these gene expression changes with age are worth investigating
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and could contribute to our understanding of why CNS axons lose their
regeneration capacity as they mature. Understanding these changes could
eventually allow us to manipulate key selected genes and transcription factors
involved in epigenetic modification to fine-tune neuronal responses after injury
in a way that turn off the growth inhibitory genes and turn off and turn on the
pro-growth genes.
Our objective in this study is to provide a comparison of the
transcription profile between isolated neurons and astrocytes in 35-day old vs
125-day old rats.
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A. Specific Aims
Mature mammalian CNS neurons do not regenerate following injury
caused by ischemia, neurodegeneration, or trauma. Multiple factors can
cause the failure of regeneration, including age related decline in intrinsic
regenerative capacity of neurons and the extrinsic inhibitory glial environment
and the lack of regenerative associated neurotrophic factors. Our central
hypothesis is that the intrinsic capacity of neuronal process outgrowth may
depend on age related changes in the epigenetic regulation of chromatin and
alterations in the accessibility of genes associated with axonal regeneration.
Many transcription factors that contribute to axonal regeneration in other
model systems have been identified. However, there is a gap in our
knowledge of the connection between transcription factors and signaling
pathways in regulating axonal regeneration in maturing CNS. To address this
issue, we used the hypothalamic neurohypophysis system, a model system
that shows a robust collateral axonal sprouting response within distal terminal
field of MCNs following unilateral denervation of the hypothalamic supraoptic
nucleus in 35-day old rat, the response is completely lost between 35 and 125
days of age. Our goal is to identify changes in gene expression and specific
pathway enrichment between young vs mature intact rat brains from both
male and female rats. To gather necessary evidence to pursue our goal, we
propose the following specific aim: To compare the transcription profile in
young vs mature hypothalamic neurons and astrocytes in the rat neural lobe
B. Significance and Innovation
This study will provide key elements in the neuronal epigenetic
landscape that contributes to the age-related alteration in the regenerative
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capacity of CNS neurons. Furthermore, our findings will contribute to the base
knowledge of transcriptional regulation in intact maturing rat brains (both
males and females) that is necessary for further investigation of maturational
alteration in neuronal plasticity in response in injury and treatments with
specific neurotrophic factors. The innovation in our proposed study is that we
will utilize a proven model of axonal regeneration with a distinct phenotypical
structure, wherein, astrocytes are intimately associated with neuronal
plasticity. We will use bioinformatic tools to assess the regeneration
transcriptome of young vs mature MCNs and astrocytes, which will represent
a new direction for our investigation of cell specific epigenetic alteration
contributing to changes in the neuronal plasticity.
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CHAPTER II
MATERIALS AND METHODS
Animals
For the RNA seq analysis, male and female Sprague Dawley rats
obtained from (Charles River Laboratories) were maintained under normal
laboratories conditions. Rats were housed in the Biomedical Research Facility
on the campus of the University of North Dakota, an AAALAC accredited
facility, with a 12-hour light: 12-hour dark cycle, with access to food and
drinking water. All procedures were carried out in accordance with the
National Institute of Health (NIH) guidelines on the care and use of animals.
35 days (about 5 weeks) old male and female rats, 125 days (about 4
months) old male and female rats as well as 90 days (about 3 months) old
rats were sacrificed for tissue collection for RNA and DNA isolations.
Perfusion
Rats were brought to the lab on the day of perfusion. All perfusions
took place during the daytime, 9am-5pm. Animals were kept separately from
each other at all times. Rats were deeply anesthetized with isoflurane and
perfused transcardially with 0.9% saline for a period of 10 minutes.
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Brain Dissection and Tissue Preparation
Animals were then decapitated right underneath the ear edges to
preserve anatomical landmarks. The brain was carefully dissected as follows:
a sagittal incision is made in the skin along the sagittal suture, carefully
opening the skull by separating the two occipital and parietal skull bones,
flipping the rat skull and carefully freeing thebrain from the meninges in the
occipital hemisphere to avoid detaching the pituitary gland from the Sella
turcica (also called pituitary fossa) that houses the pituitary gland. The brain
is then moved to a brain slicer after cutting the optic tracts. When the optic
chiasm and hypothalamus facing upward in the brain slicer, a double-edged
blade was used to make a cut right before the optic chiasm forms and another
cut right behind the hypothalamic bulb shown in the figure below, creating
a thick section that contain the supraoptic nucleus (SON).
To obtain the neural lobes, the remaining rat skull was moved under
light to carefully remove the dura and separate the neural lobe from the
anterior lobe of the pituitary gland. The neural lobe was then placed in a tube
and then placed in liquid nitrogen. After collecting four neural lobes from same
age group and gender, the sample was kept at –80 for RNA isolation.
Buffers
0.2M Sodium phosphate buffer (pH=7.4):
Add 56.8 g of Na2HPO4 dibasic anhydrous to 2L of ddH2O
Add 16.56 monobasic monohydrate in 600 ml of ddH2O
Add monobasic to dibasic solution and check to achieve the optimal
pH of 7.4
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PBS
In a large flask slide the magnetic stick in the mixture, then add 100 ml of
0.2M (Ph=7.4) phosphate buffer and 1900 ml of ddH2O, then add 17g
NaCl. Spin and mix until all the white salts disappear then keep at 4°C.
4% PFA
8% PFA is prepared in the hood then diluted down to 4% with ddH2O
■ Add 80 g paraformaldehyde powder to 1000ml of ddH2O in a flask
■ Stir and heat the mix, while covered, at 60-65 degrees until the
salts are completely dissolved.
■ Let the solution cool down then filter to get clear solution
■ Drops of NaOH were added sometimes, drop by drop, to help adjust the pH
and dissolve the remaining powder that causes the milky appearance of the
solution.
RNA isolation
Each sample contained four neural lobes from four rats of the
same age and gender (average weight of the sample taken by measuring the
weight of tube and sample and the weight of the dried out collecting tube).
RNA Isolation using the RNeasy Mini Kit
1

Clean the surfaces and objects with RNase, dry with Kim dry wipes.

2

Set your centrifuge at 4 °C before you start your protocol.
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3. Place the tissue in the bottom of RNase free collecting tube, then place
the tube in liquid nitrogen along with clean pistol for 15 s then smash
the frozen tissue completely while the tube is in the liquid nitrogen.
4. Add the Trizol reagent (Ambion by Life Technologies) 1 ml and mix
using the pistol to ensure that no tissue is left behind uncrushed.
5. Pipette to mix well. Mix is kept for next day at-80 to help dissolve
tissue.
6. In a phase lock gel column (centrifuged first) add 200ml chloroform
(Sigma-Aldrich) and the Trizol mix. Shake vigorously and incubate at
RT for 3 min
7. Spin 15 min at 12,000Xg 4 °C until it is separated. Prepare RDD and
DNase mix by adding 10 ml DNase stock solution (RNase free –
DNase set from Qiagen. Cat.No:79254) to 70 ml RDD buffer (also
included). Mix gently by inverting the tube then centrifuge for 15s then
keep on ice.
8. Transfer the aqueous phase to a collecting tube.
9. Apply 1 volume of 70% EtOH and mix (by vortex or pipette)
10. Apply the mix to the RNeasy column and spin >8000Xg 30 s/ RT.
Discard flow-through.
11. Wash the RNeasy column with 350 ml of RWT buffer (RNeasy Mini Kit
from Qiagen) (Spin >8000Xg for 15 s/ RT. Discard Flow-through.
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12. Add the DNase and RDD incubation mix, 80 ml total for each
sample. Let the mix stand on the workbench for 15min at room
temperature (RT).
13. Wash again with 350 ml of RWT buffer. Spin >8000Xg for 15s at RT.
Discard the flow-through.
14. Add 500 ml RPE buffer (RNeasy Mini Kit from Qiagen. Cat.No:74104)
to the RNeasy spin column. Centrifuge for 15 s at >8000Xg.Discard
flow-through.
15. Wash again with 500 ml RPE buffer to the RNeasy spin column.
Centrifuge for 2 min at >8000Xg. Discard flow-through.
16. Change the collection tube of RNeasy column to a new dry one, then
spin to dry for 5 min at >8000Xg at RT.
17. Elute in 50 ml nuclease free water (Qiagen). Elute again with the same
flow-through. Spin for 15s. Keep the samples in Eppendorf tubes on
ice for quantification then store at -80°C.
After each RNA isolation, RNA concentrations and purity were
measured using a microplate spectrophotometer (Gen5.2.0), blanks were
blocked using Nuclease free water.
The samples were then sent to the UND Genomic Core for sample
quality check and library preparation. The UND genomic core requires at least
1 µg or more of total RNA at a concentration of at least 50 ng/µ. RNA integrity
was evaluated by the core using gel electrophoresis to show the 28S and 18S
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rRNA bands, lower marker of 25nt for alignment and a ladder used for sizing
and quantitation. The Agilent 2100 Bioanalyzer gives each sample a number,
RNA integrity number (RIN), that reflects the integrity of RNAs in the sample.
All samples, except G2020_97_13, G2020_97_14 and G2020_97_15,
showed RIN > 9. The samples that were not assigned an RIN are showing a
small peak after the 28S rRNA peak, suggesting dimerization, a form of
secondary structure, of the RNA fragment.
RNA Sequencing
After performing quality control (QC), qualified samples proceeded to
library construction. Briefly, library construction involves cDNA fragmentation
and adaptor ligation. Adaptor-ligated fragments were then PCR amplified and
gel purified. For cluster generation, libraries were then loaded into a flow cell
to be captured by surface bound oligos complementary to the adaptors ligated
to the fragments, sequential bridge amplifications will allow for each fragment
to form a cluster, templates were ready for sequencing using the Illumina
platform that utilizes the sequencing by synthesis (SBS) technology.
Bases are detected and called for as they are being incorporated as all
four types of dNTPs are present during the amplification cycles. The
advantage of this technology is that it increases the accuracy rates and
virtually eliminates the errors in base calling. The sequencer utilizes a
software program called RTA (real time analysis) that converts raw data
images to binary base call and then into FASTQ files using an illumina
package bcl2fastq. There is no optimal pipeline for the variety of analysis
scenarios in which RNA seq can be used. However, different studies have
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shown the best practices and major steps in RNA seq data analysis (Oshlack
et al. 2010, Koch et al. 2018). Careful planning of the RNA experiment is
essential to avoid any technical bias in data collection and prior to any further
steps to ensure a statistically powerful analysis, therefore it is crucial for any
RNA seq study to start with good experimental design, that is by determining
the library type, library size and the number of biological replicates (Conesa et
al. 2016). In our study, the library was constructed with enough RNA pool, as
we pooled NLs from four rats into one sample. Since we had relatively high
proportion of mRNA in our samples, abundant rRNA were removed from the
pool by enriching for mRNA, a technique called Poly (A+) selection, which
provides a better exonic coverage and better accuracy of gene quantification
(Zhao et al. 2018). Reads were paired end (PE) which is preferable for de
novo transcripts and isoform expression analysis. Another important factor is
sequencing depth or library size, which is the number of sequenced reads for
a given sample. Deeper sequencing can detect more transcript, giving a more
precise quantification, however, it may also result in the detection of
transcriptional noise and off target transcripts. Studies have shown that
sequencing less reads and performing more biological replication is an
effective strategy to increase the power of detection in RNA seq studies (Liu
et al. 2013). Therefore, the optimal sequencing depth for our experiment was
around 30 million reads and the number of biological replicates for each
experimental group is four.
Read data were compressed in two fast.gz files for each sample.
(for example:G2020_97_1_R1.fastq.gz and G2020_97_1_R2.fastq.gz). To
analyze data, we needed to convert raw data to count data in Unix terminal:
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1. Running a fastqc, a java application for quality control check of high
throughput sequencing in terminal. Quality control for multiple files in
the same directory was run by multiqc program as well.
nohup fastqc *fastq.gz fastqc
nohup multiqc *fastq.gz multiqc
2. Trimming adaptors using Trimmomatic 0.039, forward and
reverse fastq.gz files are used as input files, four gz files are used as
trimmed reads baseout.
java -jar trimmomatic-0.39.jar PE -threads 13 -phred33
G2020_97_11_R1.fastq.gz G2020_97_11_R2.fastq.gz
11_R1P_trimmed.gz 11_R1U_trimmed.gz 11_R2P_trimmed.gz
11_R2U_trimmed.gz ILLUMINACLIP: TruSeq3-PE-2. fa: 2:30:10:2
TRAILING:3 HEADCROP:12 MINLEN:36
3. Alignment of paired ends to rat Genome using HISAT2 tool:
hisat2 -p 8 -x genome -1 15_R1P_trimmed.gz -2 15_R2P_trimmed.gz S G2020_97_15.sam
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4. Converting Sam files to Bam files and indexing Bam files and the
companion index files
samtools sort -@ 8 -o G2020_97_15.bam G2020_97_15.sam
Samtools index *.bam
5. Creating a count table of the data using FeatureCount;
a function that assigns mapped reads to genomic features and creates
a count table. Annotation .gtf files that include genomic features
were assembled by the UND genomic core from rn6 genome of Rattus
norvegicus of UCSC genome browser featureCounts -p -t exon g gene_id -a genes.gtf -o counts.txt *.bam
6. Then the files were converted from .txt to .csv
Mv count.txt count.csv
7. Count tables were imported into R studio for RNA sequencing
analysis.
RNA Seq Analysis in R Studio
To analyze the RNA seq data, we needed to compare the data of 35
days old rats to data coming from 125 days old rats and we needed to
consider the gender variation in gene expression
1. R script for comparing 35Males vs 125Males using DESeq2 package
Setwd ("/lower_bay/home/malak.alzidaneen/NL_project/featureCounts")
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# Reading in data and creating a data frame that includes four biological
replicates from each biological condition:
count_dataF <- read.delim("count.txt", skip=1)
rownames(count_dataF) <- count_dataF$Geneid
annotation <- count_dataF[,c(1:6)]
count_dataF <- count_dataF[,-c(1:6)]
colnames(count_dataF) <- gsub(".bam","",colnames(count_dataF))
colnames(count_dataF) <c("NL_125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_1
4","NL_125F_15","NL_125F_16","NL_35M_1","NL_35M_2","NL_35M_3","NL_
35M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9")
count_dataF <- count_dataF[,c("NL_35M_1","NL_35M_2","NL_35M_3","NL_3
5M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9","NL_
125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_14","NL_
125F_15","NL_125F_16")]
count_dataF <- count_dataF[c("NL_35M_1","NL_35M_2","NL_35M_3","NL_3
5M_4","NL_125M_9","NL_125M_10","NL_125M_11","NL_125M_12" )]
replicates <- c(rep("M35",4), rep("M125",4))
colData <- data.frame(row.names =
c("NL_35M_1","NL_35M_2","NL_35M_3","NL_35M_4","NL_125M_9","NL_12
5M_10","NL_125M_11","NL_125M_12"),
conditions =
c("NL_35M_1","NL_35M_2","NL_35M_3","NL_35M_4","NL_125M_9","NL_12
5M_10","NL_125M_11","NL_125M_12"),
replicates = replicates )
# Visualizing data using boxplot and histogram
boxplot(count_dataF)
# log2-transformation and visualization of the transformed data:
pseudoCount <- log2(count_dataF + 1)
boxplot(pseudoCount)
hist(pseudoCount[,1])
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# Creating DESeq2 Data Set matrix
library (DESeq2)
DEeqDataSet <- DESeqDataSetFromMatrix(countData = count_dataF,
colData = colData,
design = ~ replicates )
View (DEeqDataSet)
# Transformation
rld <- rlogTransformation(DEeqDataSet)
par(mfrow = c( 1, 2 ))# for sample NL_35M_1 (can be changed)
plot(log2( 1 + counts(DEeqDataSet)[ , 1:2] ),
pch=16, cex=0.3, main = "log2")
plot(assay(rld)[ , 1:2],pch=16, cex=0.3, main = "rlog")
# Clustering the sample-to-sample distances
library("RColorBrewer")
library("pheatmap")
distanceC <- dist(t(assay(rld)))
matrix <- as.matrix(distanceC)
rownames(matrix) <- colnames(matrix) <- with(colData(DEeqDataSet),
paste(conditions))
colors <- colorRampPalette( rev (brewer.pal(9, "GnBu")) )(100)
pheatmap(matrix,
clustering_distance_rows=distanceC,
clustering_distance_cols=distanceC,
col=colors)
# PCA plot
plotPCA(rld, intgroup=c("conditions"))
# Normalization
dds <- estimateSizeFactors(DEeqDataSet)
sizeFactors(dds)
# Differential expression analysis using DESeq2
38

library(DESeq2)
DEG <- DESeq(dds)

# DEG is the list of differentially expressed genes

plotDispEsts(DEG)
M35_vs_M125DEGres <- results(DEG,
contrast=c("replicates","M125","M35"))

# contrast M125 to M35(M35 is the

baseline)
mcols(M35_vs_M125DEGres, use.names=TRUE)
summary(M35_vs_M125DEGres)
plotMA(M35_vs_M125DEGres, ylim=c(-7,7))
write.csv( as.data.frame(M35_vs_M125DEGres),
file="M35_vs_M125results.csv" )
# Filtering the significant genes (subset the only differentially expressed
genes with padj<0.05)
SignificantGenes <- subset(M35_vs_M125DEGres, padj < 0.05)
SignificantGenes
SigG <- SignificantGenes[order(SignificantGenes$log2FoldChange,
decreasing= TRUE, na.last = TRUE),]
write.csv( as.data.frame (SigG), file="SigGene35Mvs125M.csv" )
# Viewing options
head(M35_vs_M125DEGres[order(M35_vs_M125DEGres$padj),], 100)
subset(M35_vs_M125DEGres, grepl("Oxt",rownames(M35_vs_M125DEGres)
))
plotCounts(M35_vs_M125DEGres,"S100p") # can be changed for different
genes
library("pheatmap")

# heat map of expressed genes

SFmatrix <- assay(rld)[order(SigG$padj), ]
rownames(SFmatrix)<-NULL
SFmatrix <- SFmatrix - rowMeans(SFmatrix)
dataf <- as.data.frame(colData(rld)[,c("replicates")])
colnames(dataf) <- "replicates"
rownames(dataf) <- colnames(SFmatrix)
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pheatmap(SFmatrix, annotation_col=dataf)
2. R script for comparing 35 Females vs 125 Females using DESeq2
package
# Reading in data
count_dataF <- read.delim("count.txt", skip=1)
rownames(count_dataF) <- count_dataF$Geneid
annotation <- count_dataF[,c(1:6)]
count_dataF <- count_dataF[,-c(1:6)]
colnames(count_dataF) <- gsub(".bam","",colnames(count_dataF))
colnames(count_dataF) <c("NL_125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_1
4","NL_125F_15","NL_125F_16","NL_35M_1","NL_35M_2","NL_35M_3","NL_
35M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9")
count_dataF <- count_dataF[,c("NL_35M_1","NL_35M_2","NL_35M_3","NL_3
5M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9","NL_
125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_14","NL_
125F_15","NL_125F_16")]
count_dataF <- count_dataF[c("NL_35F_5","NL_35F_6","NL_35F_7","NL_35
F_8","NL_125F_13","NL_125F_14","NL_125F_15","NL_125F_16" )]
replicates <- c(rep("F35",4), rep("F125",4))
colData <- data.frame(row.names =
c("NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125F_13","NL_125
F_14","NL_125F_15","NL_125F_16"),
conditions =
c("NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125F_13","NL_125
F_14","NL_125F_15","NL_125F_16"),
replicates = replicates )
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# Visualizing count data
boxplot(count_dataF)
hist(count_dataF[,1]) # Plotting (column 1)
# log2-transform
pseudoCount <- log2(count_dataF + 1)
boxplot(pseudoCount)
hist(pseudoCount[,1])
#Deseq2 Data Set
library(DESeq2)
DEeqDataSet <- DESeqDataSetFromMatrix(countData = count_dataF,
colData = colData,
design = ~ replicates )
# log Transformation of normalized data and its effect
rld <- rlogTransformation(DEeqDataSet)
par(mfrow = c( 1, 2 )) # for sample NL_35M_1 (can be changed)
plot(log2( 1 + counts(DEeqDataSet)[ , 1:2] ),
pch=16, cex=0.3, main = "log2")
plot(assay(rld)[ , 1:2],pch=16, cex=0.3, main = "rlog")
# Clustering the sample-to-sample distances
library("RColorBrewer")
library("pheatmap")
distanceC <- dist(t(assay(rld)))
matrix <- as.matrix(distanceC)
rownames(matrix) <- colnames(matrix) <- with(colData(DEeqDataSet),
paste(conditions))
colors <- colorRampPalette( rev (brewer.pal(9, "GnBu")) )(100)
pheatmap(matrix,
clustering_distance_rows=distanceC,
clustering_distance_cols=distanceC,
col=colors)
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# PCA plot
plotPCA(rld, intgroup=c("replicates"))
# Normalization
dds <- estimateSizeFactors(DEeqDataSet)
sizeFactors(dds)
# Differential expression analysis
DEG <- DESeq(dds)
plotDispEsts(DEG)
F35_vs_F125DEGres<- results(DEG, contrast=c("replicates","F125","F35"))
mcols(F35_vs_F125DEGres, use.names=TRUE)
summary(F35_vs_F125DEGres)
plotMA(F35_vs_F125DEGres, ylim=c(-7,7))
write.csv( as.data.frame (F35_vs_F125DEGres),
file="F35_vs_F125Dresults.csv" )
# Filtering the significant genes with FDR <0.05 :
SignificantGenes <- subset(F35_vs_F125DEGres, padj < 0.05)
SignificantGenes
SigG <- SignificantGenes[order(SignificantGenes$log2FoldChange,
decreasing= TRUE, na.last = TRUE),]
write.csv( as.data.frame (SigG), file="SigGene35Fvs125F.csv" )
# Visualization options
head(F35_vs_F125DEGres[order(F35_vs_F125DEGres$padj),], 100)
Library ("pheatmap")
SFmatrix <- assay(rld)[order(SigG$log2FoldChange), ]
SFmatrix <- SFmatrix - rowMeans(SFmatrix)
rownames(SFmatrix)<-NULL
dataf <- as.data.frame(colData(rld)[,c("replicates")])
colnames(dataf) <- "replicates"
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rownames(dataf) <- colnames(SFmatrix)
pheatmap(SFmatrix, annotation_col=dataf)
3. R script for comparing 35D (both males and females )vs 125D(
both males and females) using DESeq2 package:
# Reading in data
count_dataF <- read.delim("count.txt", skip=1)
rownames(count_dataF) <- count_dataF$Geneid
annotation <- count_dataF[,c(1:6)]
count_dataF <- count_dataF[,-c(1:6)]
colnames(count_dataF) <- gsub(".bam","",colnames(count_dataF))
colnames(count_dataF) <c("NL_125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_1
4","NL_125F_15","NL_125F_16","NL_35M_1","NL_35M_2","NL_35M_3","NL_
35M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9")
count_dataF <- count_dataF[,c("NL_35M_1","NL_35M_2","NL_35M_3","NL_3
5M_4","NL_35F_5","NL_35F_6","NL_35F_7","NL_35F_8","NL_125M_9","NL_
125M_10","NL_125M_11","NL_125M_12","NL_125F_13","NL_125F_14","NL_
125F_15","NL_125F_16")]
replicates <- c(rep("35D",8), rep("125D",8))
View(replicates)
colData <- data.frame(row.names =
c("NL_35M_1","NL_35M_2","NL_35M_3","NL_35M_4","NL_35F_5","NL_35F_
6","NL_35F_7","NL_35F_8","NL_125M_9","NL_125M_10","NL_125M_11","NL
_125M_12","NL_125F_13","NL_125F_14","NL_125F_15","NL_125F_16"),
conditions =
c("NL_35_1","NL_35_2","NL_35_3","NL_3_4","NL_35_5","NL_35_6","NL_35_
7","NL_35_8","NL_125_9","NL_125_10","NL_125_11","NL_125_12","NL_125
_13","NL_125_14","NL_125_15","NL_125_16"),
replicates = replicates )
# Visualizing data
boxplot(count_dataF)
hist(count_dataF[,1]) # Plotting (column 1)
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# log2-transform
pseudoCount <- log2(count_dataF + 1)
boxplot(pseudoCount)
hist(pseudoCount[,1])
#Deseq2 Data Set
library(DESeq2)
DEeqDataSet <- DESeqDataSetFromMatrix(countData = count_dataF,
colData = colData,
design = ~ replicates )
# Transformation
rld <- rlogTransformation(DEeqDataSet)
par(mfrow = c( 1, 2 ))# for sample NL_35M_1 and NL_35M_2 (can be
changed)
plot(log2( 1 + counts(DEeqDataSet)[ , 1:2] ),
pch=16, cex=0.3, main = "log2")
plot(assay(rld)[ , 1:2],pch=16, cex=0.3, main = "rlog")
# Clustering the sample-to-sample distances
library("RColorBrewer")
library("pheatmap")
distanceC <- dist(t(assay(rld)))
matrix <- as.matrix(distanceC)
rownames(matrix) <- colnames(matrix) <- with(colData(DEeqDataSet),
paste(conditions))
colors <- colorRampPalette( rev (brewer.pal(9, "GnBu")) )(100)
pheatmap(matrix,
clustering_distance_rows=distanceC,
clustering_distance_cols=distanceC,
col=colors)
# PCA plot
plotPCA(rld, intgroup=c("replicates"))
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# Normalization
dds <- estimateSizeFactors(DEeqDataSet)
sizeFactors(dds)
# Plot the normalized counts and compare to before normalization
library(reshape2)
boxplot(pseudoCount)
norm_counts <- counts(dds, normalized = TRUE) # Extract the normalized
counts
pseudoCount <-log2(norm_counts + 1) # convert to log-scale for
visualization

# Differential expression analysis
DEG <- DESeq(DEeqDataSet)
plotDispEsts(DEG)
DEGres <- results(DEG, contrast = c("replicates", "125D", "35D"))
mcols(DEGres, use.names=TRUE)
summary(DEGres)
plotMA(DEGres, ylim=c(-7,7))
write.csv( as.data.frame (DEGres), file="35D_vs_125Dresults.csv" )
# Filtering the significant genes with FDR < 0.05
SignificantGenes <- subset(DEGres, padj < 0.05)
SignificantGenes
SigG <- SignificantGenes[order(SignificantGenes$log2FoldChange,
decreasing= TRUE, na.last = TRUE),]
write.csv( as.data.frame (DEGres), file="DEGres35vs125.csv" )
# Plot the significant genes (heatmap)
library("pheatmap")
SFmatrix <- assay(rld)[order(SigG$pvalue),]
SFmatrix <- SFmatrix - rowMeans(SFmatrix)
rownames(SFmatrix) <-NULL

45

dataf <- as.data.frame(colData(rld)[,c("replicates")])
colnames(dataf) <- "replicates"
rownames(dataf) <- colnames(SFmatrix)
pheatmap(SFmatrix, annotation_col= dataf)
Functional Enrichment Analysis
String version 11.0 (available through STRING consortium
2020) was utilized to perform functional enrichment analysis on a specified
gene set to identify global networks including direct (physical) and indirect
(functional) networks. Two different gene lists representing the differentiated
genes were uploaded to the program software, functionally protein associated
with each gene was identified and the whole genome of Rattus Norvegicus
was set as a statistical background set.
Ingenuity Pathway Analysis
Pathway analysis was performed using the web-based Ingenuity
pathway analysis (IPA) software provided from Qiagen. A list of differentiated
genes (padj < 0.05) genes from each group was imported into the program,
log2FC ranging between –0.5 to 0.5 was used as a cutoff for analysis. The
software automatically recognized the array platform, and we selected
the flexible file format. Each dataset had one observation but also contained
information on the expression intensity, expression fold change and log ratio,
P values and adjusted p-values (FDR) as well. Once the data sets were
ready, we ran the core expression analysis based on the expression log fold
change. The analysis was set to detect direct and indirect relationships, and
to generate interaction networks as well as causal networks.
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Immunohistochemistry Studies
Immunohistochemistry was utilized to visualize the supraoptic nucleus,
oxytocinergic and vasopressenergic neuronal cell bodies and axonal tracts
passing through the median eminence to reach their terminal field in the
neural lobe. The IHC protocol contains many steps that require optimization to
ensure specific antibody binding and optimal visualization of the target
protein. For our study we performed the IHC study as follows:
DAY1: Tissue Preparation
Animals were euthanized using isoflurane and then perfused transcardially
with PBS for 3-4 min followed by 4% PFA for 10-15 min using a Master flex
pump L/S compact drive at medium rate. Perfusion was followed by
brain dissection (as discussed before) to isolate the Neural Lobe and a
hypothalamic section that contains the SON. The tissues were post fixed in a
glass jar completely covered in 4% PFA overnight at 4°C to help prevent cell
shrinkage during the subsequent sucrose preservation.
Day 2: First Sucrose Immersion
Cryopreservation using the sucrose solution to prevent ice crystal formation
and keep the tissue integrity:
Prepare 30 % sucrose (Sigma life science) by pipetting 80 ml of PBS in
a flask
Weigh 30 g sucrose and add it to the PBS and stir. Add more PBS to
make it up to 100 ml, if necessary.
Wash your tissue 3 times with PBS to remove any remaining PFA.
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Prepare 15% sucrose by adding 50 ml of PBS to half the amount of
30% sucrose, leave 50 ml for the second treatment.
Add the 15% sucrose to completely fill the jar and leave overnight at
4°C. The tissue should float in the beginning and then sink to the bottom
overnight.
Day 3: Second Sucrose Immersion
Change the sucrose to 30% and fill the container.
Leave overnight at 4°C until it sinks again
Day 4: embedding tissue in OCT.
Flash freezing: Brain tissue is removed from the sucrose and placed,
SON facing down, inside a cryomold containing OCT (tissue freezing
compound /Leica). Then the mold is placed inside a tube with 2-methylbutane
(Sigma Aldrich) then placed immediately in the liquid nitrogen.
Labelled samples are kept overnight in a sealed freezing bag (wrapped in
foil) at –20 until ready for sectioning.
Day 5: Cryosectioning
The cryomold was removed and OCT containing the tissue was
mounted on the sample stub using the same OCT and placed on the chuck,
adjusted the blade at 10 degrees and fixed the anti-roll plate. Everything in
the cabinet should be left for at least 30 min to bring the temperature to –
20°C to prevent tissue curling or damage during sectioning. Using Cryostat
(Micron HM 550), thin coronal sections (around 14 µm) were made then
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mounted on subbed microscope slides (VWR microscope slides). Slides
were stored in a sealed slides box at - 20°C until ready for staining.
For staining: PBS, blocking serum 4% (compatible with the 2ry
antibody)/same species )1ry antibody, 2ry antibody carrying a fluorophore for
detection.
Procedure for oxytocin (OXT), vasopressin (Avp) and astrocytes
(GFAP) staining:
1. Place the labelled brain section slides in the jar. Positive and negative
control slides were used to set up a threshold for background
staining. GFAP, an astrocyte marker, is used as a positive control.
2. Add PBS and place the jar on the rocker for 10 min to wash
3 times with PBS ,10 min for each wash.
3. Prepare blocking serum(BS) 4% using normal goat serum and PBS
to mitigate the nonspecific binding.
4. In a tray add tap water on the edges, wipes the slide from the back
place the slides, add 6 drops of BS over the tissue, cover the tray and
leave for 1 hour.
5. Prepare primary antibody at 1:250 concentration using blocking serum
to dilute the antibodies (see all antibodies used in the experiment in the
supplementary tables).
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6. Wick the BS off the slide and clean the slide around the tissue with a
Kim wipe.
7. Apply the primary antibodies (6 drops) on each tissue except for the
negative control.
8. Leave at room temp overnight covered to avoid dehydration
9. Prepare the secondary antibodies that are compatible with the serum
used for blocking antigens at concentration 1:200 using PBS for
dilution.
10. Then wash the slides using PBS three times for 10 min each time.
11. Apply 6 drops of secondary antibodies to each slide
12. Leave at RT slides covered overnight
13. Wash the slides, while covered, three times, 10 minutes each.
14. For visualization: wick off the remaining PBS, dry around the tissue,
apply a line of mounting medium for florescence (Vectashield H-1200
/vector labs/Southern Biotech cat NO 100-20) with DAPI stain and
cover with a microscopic glass slipcover (VWR international). Olympus
microscope BX-51 was used to visualize the slides. Representative
images where then recorded using the accompanying camera DP-71
Optimizing the exposure time and intensity using the dedicated
software.
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RT-qPCR for Validation of RNA Sequencing:
Protocol for cDNA Synthesis using the RT2 First Strand Kit
400 ng total RNA from each sample were used for format E and G 384
(4 x 96)
Procedure
1. Thawed the reagents of the RT2 First Strand Kit. Briefly centrifuge
(10–15 s) to bring the contents to the bottom of the tubes.
2. Prepared the genomic DNA elimination mix for each RNA sample
according to this table. Mix gently by pipetting up and down and
then centrifuge briefly.
Genomic DNA elimination mix Component Amount
RNA*

25 ng – 5 µg (I used 400ng

Buffer

GE 2 µl

RNase-free water

Variable (bring the volume up to 10µl)

*Volumes used are in separate supplementary file.
Total volume 10 µl
No reverse transcriptase (NORT) samples; to test for any
background DNA contamination, were prepared as well by pooling RNAs
from 4 samples that belonged to one replicate group (35M1-4, 35F14, 124M1-4, 125F1-4) and used the same volume of RNA (2µl). For NoRT
reactions we did not use reverse transcriptase, we used nuclease free water
instead.
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3. Incubated the genomic DNA elimination mix for 5 min at 42°C, then placed
the mix immediately on ice for at least 1 min.
4. Prepared the reverse-transcription mix

Reverse-transcription Mix Components:
Volume for 1 reaction

Volume for 2 reactions

5x Buffer BC3

4 µl

8 µl

Control P2

1 µl

2 µl

RE3 Reverse

2 µl

4 µl

RNase-free water

3 µl

6 µl

Total volume

10 µl

20 µl

Transcriptase Mix

5. Add 10 µl reverse-transcription mix to each tube containing 10 µl genomic
DNA elimination mix. Mix gently by pipetting up and down.
6. Incubate at 42°C for exactly 15 min. Then immediately stop the reaction by
incubating at 95°C for 5 min.
7. Add 80 µl RNase-free water to each reaction. Mix by pipetting up and down
several times (total volume of 100µl)
8. Place the reactions on ice and continue with the realtime PCR protocol. Libraries were stored at –80 for later.
Real time PCR using qPCR Primer Assay (see appendix II for the list of
primers used) and RT SYBR Green Master mixes
1.Briefly centrifuged the RT2 SYBR® Green Master mix (10–15 s) to bring the
contents to the bottom of the tube.
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2. Prepared the PCR components mix in a 5 ml tube or a loading reservoir
depending on the RT2 Profiler PCR Array format, as described
For using Array format 384 (4 x 96) we prepared a master mix for each gene
Components of the master mix enough for one Reaction:
RT2 SYBR® Green Master mix

11 µl

qPCR primer assay

2.2µl

RNase-free water

6.8µl

3. Added 20 µl of the prepared master mix to the PCR wells then add cDNA
synthesis reaction to each well except the NTC (add nuclease free water
instead) / total volume in each well is 22µl
For each gene we tested we had:
Three technical replicates for each sample, for 16 samples we had a total of
48 wells.
Four NORT ells each well represent a biological group.
One no template well where we used nuclease free water instead of DNA
template to compensate for the volume gap
*Total number of reactions needed to test each gene was 53. In addition to
the 10% volumes added to account for pipetting errors as well
4. Covered the plate with plastic adhesive cover and sealed the edges
5. Centrifuged the covered plate to get rid of any bubbles
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6. Place the plate in the real time Cycler (BIO-RAD CFX384) and determine
the layout of samples on the plate and set the cycler conditions as below:
Cycle 1

for 10 Min

at 95°C

Cycles 2-39

for 15s

at 95°C

1min

at 60°C

For the melting curve setting 95°C for 1min, 65° for 2 min, 65°C to 95°C at
a rate 2°C/min (which means 0.5°C every 15s)
7. Close the lid and run the qPCR
8. Analyze the qPCR data
Statistical Analysis of qPCR Data
To analyze quantitative PCR data acquired from PCR experiments we
utilized LinRegPCR, a data analysis model used to calculate amplification
efficiencies from individual amplification plot. Non baseline corrected data
were imported into the program; the program corrects the baseline for each
sample separately, determines a window of linearity and calculates the slope
of regression line using linear regression model and it sets the threshold of
florescence to determine the Cq values.
The average amplification efficiency is calculated for each amplicon when the
samples that belong to each amplicon are set in groups. The next step is to
calculate the delta delta Ct (ΔΔ Ct) values, one of the most popular methods
to calculate changes in expression between control and other samples in real
time PCR experiments with a single reference gene for normalization. ACTB
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gene was used as a reference gene in the calculations considering the stable
expression of this gene in different cell lines and its already established use in
aging models (González-Bermúdez L, et al. 2019). Calculations were
carried out for each gene as follows:

1. Calculated the mean of Cq values of the three technical replicates of
each sample
2. Calculated the difference between mean Cq of the gene and the mean
Cq of the reference gene
3. The average of Δ Cq for the control groups (35M and 35F) were
calculated
4. Calculated the change between the Δ Cq of each sample and the
average ΔCq of control to determine the ΔΔ Cq
5. Calculated the fold change in gene expression, 2 to the power of
negative ΔΔ Ct:
Fold gene expression = 2^-(∆∆Ct)
6. For statistical analysis and easier interpretation, we transformed the
values using log2 transformation function in Excel.
Statistical analysis was performed using
the Qbase+ software (Biogazelle). The Excel run file that includes quantitative
data from the qPCR experiments imported into a new project into the program
user interface. Calculation parameters included normalization to a reference
target gene (ACTB) and scaling to a control group. Each analysis was run
55

separately (35 M and 35F) and control groups were used as a scaling
reference in two separate analyses. Quality control setting included was set to
remove any well that has a Cq exceeding the 35 thresholds. In the stat
wizard, the program automatically determines the suitable test according to
the experiment and samples properties. Analysis was performed using
unpaired T test and allowed to correct for multiple testing.
Pearson correlation was implemented to examine the concordance
between RNA seq gene expression data and RT-PCR gene expression of
certain genes, and (r) Pearson correlation coefficient was calculated in
Excel using the formula:
Pearson Correlation Coefficient = ρ (x, y) = Σ (xi – x̄) (yi – ȳ)
/ σx*σy Xi, yi: input/variables / x̄: mean of x / ȳ: mean of y / σx: standard
deviation (SD) of x σy: SD of Y
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CHAPTER III
RESULTS
Immunohistochemistry
Immunohistochemistry imaging of the SON shows the vasopressin
neuronal cell bodies adjacent to the optic chiasm (Figure 4/I-a) which is
devoid of cell bodies as shown in the images (I-a /2a). Nuclei of vasopressin
neurons are apparent in(I-b) using DAPI stain and using the FITC along with
large neuronal soma. Negative control image (III-a) is devoid of cell bodies of
magnocellular neurons in the SON. Positive control image (III-b) shows the
astrocytic cells stained by GFAP in the SON with their thin finger-like process
extending from the VGL to occupy spaces in between cell bodies of
magnocellular neurons and along the blood vessel that passes through the
SON.
Magnocellular neurons pass through the median eminence on their
way down to reach their terminal field, neurohypophysis. Images here show
the oxytocinergic neuronal axons (IV-b) and vasopressinergic neuronal axons
(IV-a) passing through median eminence, it appears as a bridge between the
two edges of the third ventricle.
Once the magnocellular neurons reach their terminal field,
oxytocinergic neurons usually enter the field later compared to the
vasopressinergic neurons which enter the field medially toward the center of
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neural lobe parenchyma. Images here show the oxytocin neuronal axons
(V-a) and vasopressin neurons (V-b) in a cross section of neural lobe.
I-a

II-a

I-b

II-b

58

III-a

III-b

IV-a

IV-b
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V-a

V-b

Figure 4. IHC of supraoptic nucleus, median eminence, and neural lobe.
I-a shows the vasopressin (AVP) neurons cell bodies and nuclei at 20X; VGL
is devoid of MCN cell bodies. I-b shows nuclei of AVP neurons in the SON
using DAPI (blue) at 20X.
II-a shows oxytocin (Oxt) neuron cell bodies and nuclei at 20X. II-b shows Oxt
nuclei in the SON using DAPI stain (blue) at 20X.
III-a is negative control with no apparent signal. III-b is a positive control with
apparent Gfap signal indicative of glial presence. BV blood vessel. OC optic
chiasm.
IV-a/b shows Avp and OXT axons passing through median eminence,
respectively, 3V third ventricle. V-a/b shows Oxt and Avp axons and terminal
ends, respectively, in the terminal field (NL) at 10X.
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RNA Sequencing
Following RNA isolation from all 16 samples, DNA libraries for
sequencing were prepared and then sequenced as outlined in the method
section The Agilent 2100 Bioanalyzer gave each sample a number, RNA
integrity number (RIN), that reflects the integrity of RNAs in the sample. All
samples, except G2020_97_13, G2020_97_14 and G2020_97_15, showed
RIN > 9. The samples that were not assigned an RIN are showing a small
peak after the 28s rRNA peak, suggesting dimerization, a form of secondary
structure, of the RNA fragment. The raw data statistics (APPENDIX I) showed
in table 1 shows that samples had an acceptable Phred quality score; paired
end reads length were 151.
Following the trimming of adaptor sequences using Trimmomatic- 0.39,
we performed alignment as outlined in the methods section. Table 2
(APPENDIX I) shows the alignment rates for each sample.
RNA Seq Analysis
RNA sequence analysis was performed using the DESeq2 package in R
studio. DESeq2 package integrates a methodology that estimate effect size
(logarithmic fold change), estimate the dispersion fits a model and rank
genes, all these features improve the stability of analysis and focus on the
strength rather than the mere presence of differential expression of genes
(Love et al. 2014) Figure 5a shows heat maps of sample clustering based on
the sample-to-sample distance. Figure 5b shows the principal component
analysis and the variance among groups as we can see there is a clear age
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dependent clustering of the samples, but we also noticed the gender-based
clustering among males and females

5a

5b

Figure 5. Sample Hierarchical Clustering and Principal Component Analysis
comparing the 125 days old to 35 days old replicates.
5a shows the sample clustering based on the sample-to-sample distance. 5b
is the principal component analysis showing the age and gender-based
clustering with PCA 1 around 60% and PCA 2 around 17%.
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6a

6b

Figure 6. MA plot and Heatmap of genome wide transcriptome expression of
125 day old compared to 35day old rats. Genes with Log fold change of 0
means that fold change is 1, all genes above log Fold Change of 0 are
upregulated and all genes below Log Foldchange of 0 are upregulated and all
genes below Log Foldchange of 0 are down regulated. Redlines are log fold
change threshold of 0.5 to -0.5.
Figure 6b is a heat map of 600 DEGs with the lowest padj (FDR)< 0.05
showing the pattern of gene expression between biological replicates. Heat
map scale red (upregulated) and blue (downregulated).

Figure 6a shows the MA plot constructed to show a genome wide
transcriptome expression of two compared groups. All dots indicate
differentially expressed genes (DEGs), plotted as a function of log fold change
versus mean of normalized counts. Blue dots refer to differentially expressed
genes with adjusted p value < 0.05 as a cutoff. The red line indicates the log
fold change threshold, wherein all dots above the redline indicate genes with
a log fold change of 0.5 are upregulated and all the dots below the redline a
log fold change of -0.5 indicate downregulated genes. Using an adjusted P
value <0.1 and no fold change cutoff, there were 3180 upregulated genes and
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3401 downregulated genes. Filtering the significant genes with a more
stringent adjusted p value of <0.05 reduced the number of genes to 2746
upregulated genes and 2909 downregulated genes. A heatmap showing 600
genes with the lowest padj (Figure 6) shows the pattern of expression of
those genes mainly between the two groups of replicates; the 125 day old and
the 35 day old. The heatmap clearly demonstrates the age-based difference
between the two age groups. However, since we noticed the gender-based
difference as well, we added another level of analysis, where we also
compared the 35 day old samples from females to 125 day old females
sample as well as 35 day old male vs 125 day old male.
RNA Seq Analysis Comparing 35 Days Old Female vs 125 Days Old
Female and 35 Day Old Male vs 125 Day Old Males
To investigate the gender-based difference in gene expression pattern
between males and females, we ran two separate RNA seq analyses and
found that with a padj <0.05, there is a total of 5528 differentially expressed
genes (SigDEG) between the two female age groups; 2748 are upregulated
genes and 2775 are downregulated genes (Figure 7) compared to a total of
2582 differentially expressed genes (SigDEG) between the two males age
groups; 1246 are upregulated genes and 1336 are downregulated genes
(Figure8). We also investigated the overlap (Figure 9) between the list of
upregulated and downregulated genes in male and female groups and found
a total of 1005 genes that are upregulated in both males and females, and
1050 downregulated genes in both males and females. Furthermore, we
investigated SigDEGs between males vs females at age 35 days and males
vs females at 125 days. Figure 10 shows that there are 24 DEGs that are
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differentially expressed when contrasting 35F to 35M, among those genes
there were 4 upregulated genes and 20 downregulated genes. On the other
hand, RNA Seq analysis comparing the 125 Females to 125 Males showed a
total of 1079 SigDEGs: 489 upregulated genes and 590 downregulated
genes.
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Figure 7. RNA seq analysis of 35 days old female vs 125 days old female.
7a shows the hierarchical clustering based on sample-to-sample distance.
7b is the principal component analysis that shows 81% variance among the
35F and 125F groups. 7c is a MA plot that s
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Figure 8. RNA seq analysis of 35 old day male vs 125 days old male. RNA
seq analysis of 35 days old male vs 125 days old males. 8a shows the
hierarchical clustering based on sample-to-sample distance. 8b is the
principal component analysis that shows 70% variance among the 35F and
125F groups. 8c is a MA plot that shows all DEGs (grey dots) and DEGs with
padj <0.05 (blue dots), redlines are the log fold change threshold of -0.5and
0.5. Log FC =0 means that FC is 1. 8d is a heatmap representation of 600
genes with the lowest padj.
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Figure 9. Overlap SigDEGs (padj <0.05) between males and females. The
overlap indicates the number of differentially expressed genes between the
35-day old and 125- day old in both males and females. Orange
circle(female), blue circle(males). MA plots (9a/9b) represent the DEGs, it
clearly shows that number of DEGs in female group is as twice as many in the
male group.
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Figure 10. MA plot showing the number of SigDEGs (padj <0.05) when
comparing 35 F vs 35M groups (10a) and SigDEGs when comparing 125F vs
125M. 10b shows more DEGs (blue dots).
STRING Analysis
STRING (a search tool for retrieval of interacting genes) database was
utilized to study protein–protein interaction networks and functional
enrichment of upregulated and downregulated DEGs. By providing a list of
genes, STRING can identify associated proteins and identify the association
between these genes based on experiments and known databases that have
previously identified these interactions. STRING analysis output also includes
lists of functional enriched pathways using Gene Ontology, KEGG pathway
analysis. Each node in the network represents a gene/protein. Lines inbetween nodes represent an interaction. Figure 11 shows the network of
upregulated SigDEGs (padj<0.05) between 35 and 125 from both males and
females. Table 1 shows a list of selected functional pathways.
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Table 1: Functional Enrichment analysis of upregulated SigDEGs (35
days vs 125 days) using STRING
Pathway

False Discovery
Rate (FDR)

GO Term/

Synapse organization

0.0099

GO:0050808

Regulation of synaptic plasticity

0.0379

GO:0048167

Antigen processing and presentation

0.00010

rno04612

Cell adhesion molecules

0.00013

rno04514

Transcription factor AP-1 complex

0.0034

GO:0035976

MHC class II protein complex

0.0457

GO:0042613

Neuron projection terminus

1.16e-08

GO:0044306

70

KEGG Term

Figure 11. STRING Network of upregulated SigDEGs (35 Days vs 125 Days
old). Red nodes refer to genes related to antigen processing and
presentation. Blue nodes refer to genes involved in neuron projections.
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Table 2: Functional enrichment analysis of downregulated SigDEGs (35
days vs 125 days)
Pathway
False
GO Term/KEGG
Discovery

Term

Rate (FDR)
Extracellular matrix

2.34e-08

GO:0030198

organization

0.0409

GO:0048699

Generation of neurons

0.0415

GO:0022008

Neurogenesis

0.00032

GO:0023052

Signaling

0.0037

GO:0007165

Signal transduction
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Figure 12. STRING network of downregulated SigDEGs (35 Days vs 125
Days old). Green nodes refer to genes related to regeneration of neurons.
Red nodes represent neurogenesis. Yellow nodes indicate genes involved
cell communication. Purple dots refer to genes involved in signaling.
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Ingenuity Pathway Analysis (IPA)
The web-based bioinformatics analysis tool allows the investigator to
upload gene expression dataset and perform core functional analysis using
specific parameters, a powerful tool that not only uses the mere association
between gene expressions but also implements the direction of effect (Kramer
et al.2014). IPA uses an algorithm to investigate the pattern of gene
expression and two statistical score systems to determine the significance of
enriched pathway (p value) and the Z-score to indicate the likely activation
state of the enriched pathway. We ran different core analyses on the list of
DEGs between 35 female and 125 female group, DEGs of 35 male vs 125
males, and since we noticed a gender-based difference in gene expression,
we also ran analyses on differentially expressed genes comparing 35 male vs
35 female as well as 125 male vs 125 female to investigate the difference in
gene expression between males and females at different ages as shown in
(Figure 7 and 8).
IPA parameters used for all analyses were the same: log2 fold change
ranging between -0.5 and 0.5, padj <0.05. (Figure 13) shows the canonical
pathways enriched in each group and its clear that there are pathways with
biological significance to our question that ranked among the top significantly
enriched pathways: the activation inflammatory signaling pathway and the
axonal guidance pathway which IPA could not predict an activation state,
probably because the weight of evidence of activation equals the weight of
evidence for inhibition. Therefore, there is no prediction toward one of the
directions over the other.
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Figure 13. Top canonical pathways enrichment. Top enriched canonical
pathways between 35 F vs 125F(13-A) and between 35M vs 125M(13-B).
Cutoffs allowed genes with log2FC between -0.5 and 0.5 to be included in the
analysis. Orange line indicating the threshold of significance of enrichment. All
pathways shown here are highly significant. Longer bars reflect higher
enrichment significance. Bars with orange colors reflect a positive z-score and
are more likely to be activated. Blue bars indicate negative z-score and
therefore the pathways are more likely to be inhibited.
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Table 3: Axonal guidance molecules in 35 Female vs 125 Female group
Symbol
Rob3
Wnt10A
Epha3
Tuba8
Prkcg
Ecel1
Pak3
Wnt6
Bdnf
Itgb6
Baiap2
Lingo1
Epha1
Bmp6
Sema4F
Prkcb
Mmp28
Plcl1
Sema3D
Mmp11
Sema3B
Adam1A
Shank2
Sema5A
Pdgfc
Arhgef15
Plce1
Srgap1

GENE NAME
roundabout guidance
receptor 3
Wnt family member
10A
EPH receptor A3
tubulin alpha 8
protein kinase C
gamma
endothelin converting
enzyme like 1
p21 (RAC1) activated
kinase 3
Wnt family member 6
brain derived
neurotrophic factor
integrin subunit beta
6
BARIMD domain
containing adaptor
protein 2
leucine rich repeat
and Ig domain
containing 1
EPH receptor A1
bone morphogenetic
protein 6
ssemaphorin 4F
protein kinase C beta
matrix
metallopeptidase 28
phospholipase C like
1 (inactive)
semaphorin 3D
matrix
metallopeptidase 11
semaphorin 3B
a disintegrin and
metallopeptidase
domain 1a
SH3 and multiple
ankyrin repeat
domains 2
semaphorin 5A
platelet derived
growth factor C
Rho guanine
nucleotide exchange
factor 15
phospholipase C
epsilon 1
SLIT-ROBO Rho
GTPase activating
protein 1

EXPR LOG
RATIO

EXPR
P-VALUE

Padj

3.325

1.16E-07

1.15E-06

2.78

8.60E-06

5.76E-05

1.933

1.42E-05

9.01E-05

1.852

8.42E-18

3.45E-16

1.638

1.10E-21

6.68E-20

1.335

1.26E-02

3.43E-02

1.106

1.41E-05

8.96E-05

1.034

4.29E-10

6.61E-09

0.984

1.55E-03

5.71E-03

0.925

3.38E-10

5.28E-09

0.885

2.26E-12

4.75E-11

0.771

4.05E-20

2.04E-18

0.73

4.17E-05

2.37E-04

0.699

1.15E-10

1.92E-09

0.654

1.69E-12

3.61E-11

0.639

1.91E-13

4.66E-12

0.619

2.08E-03

7.38E-03

0.614

2.21E-11

4.08E-10

0.604

6.90E-06

4.72E-05

0.589

5.95E-08

6.23E-07

0.555

8.29E-06

5.57E-05

0.527

8.09E-04

3.23E-03

0.517

5.04E-07

4.42E-06

-0.507

8.98E-09

1.09E-07

-0.514

3.41E-05

1.98E-04

-0.547

2.02E-03

7.20E-03

-0.558

1.01E-06

8.35E-06

-0.562

7.75E-03

2.28E-02
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Unc5D
Smo
Gng3
Ntrk2
Gli3
Arpc1B
Prkd3
Tubb6
Nrp2
Myl9
Tubb

Adamts5
Tuba1C
Efna1
Bmp2
Mmp14

Adamts2
Fzd9
Itga5

Adamts9
Rac2
Plxnd1
Pik3R1

Adamts7
Cxcr4
Wnt4
Plcl2

unc-5 netrin receptor
D
smoothened, frizzled
class receptor
G protein subunit
gamma 3
neurotrophic receptor
tyrosine kinase 2
GLI family zinc finger
3
actin related protein
23 complex subunit
1B
protein kinase D3

-0.562

8.09E-09

9.99E-08

-0.581

7.81E-11

1.34E-09

-0.585

3.94E-12

8.12E-11

-0.589

6.46E-28

6.21E-26

-0.613

8.88E-09

1.08E-07

-0.63

9.36E-15

2.78E-13

-0.637

7.17E-14

1.87E-12

tubulin beta 6 class V

-0.649

5.04E-08

5.35E-07

neuropilin 2

-0.672

1.12E-10

1.88E-09

myosin light chain 9

-0.673

1.01E-11

1.99E-10

tubulin beta class I
ADAM
metallopeptidase
with thrombospondin
type 1 motif 5
tubulin alpha 1c

-0.676

2.29E-38

4.86E-36

-0.68

2.56E-04

1.19E-03

-0.689

1.24E-03

4.69E-03

ephrin A1
bone morphogenetic
protein 2
matrix
metallopeptidase 14
ADAM
metallopeptidase
with thrombospondin
type 1 motif 2
frizzled class
receptor 9
integrin subunit alpha
5
ADAM
metallopeptidase
with thrombospondin
type 1 motif 9
Rac family small
GTPase 2
plexin D1
phosphoinositide-3kinase regulatory
subunit 1
ADAM
metallopeptidase
with thrombospondin
type 1 motif 7
C-X-C motif
chemokine receptor
4
Wnt family member 4
phospholipase C like
2

-0.701

1.57E-05

9.86E-05

-0.704

1.31E-02

3.55E-02

-0.733

3.97E-05

2.27E-04

-0.742

3.07E-10

4.81E-09

-0.744

4.24E-06

3.03E-05

-0.746

4.00E-07

3.58E-06

-0.765

3.89E-14

1.05E-12

-0.768

8.74E-08

8.88E-07

-0.807

1.24E-09

1.77E-08

-0.87

6.15E-29

6.54E-27

-0.955

1.67E-08

1.93E-07

-0.966

1.08E-12

2.37E-11

-0.971

1.49E-07

1.45E-06

-0.981

2.59E-61

1.58E-58
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Unc5B
Adam19
Gnb4
Itga8
Itgb3
Ntrk3
Igf1
Mmp2
Mmp12
Ace2

Adamts12

Adamts18
Mmp9
Mmp8
Mmp13
Kel

unc-5 netrin receptor
B
ADAM
metallopeptidase
domain 19
G protein subunit
beta 4
integrin subunit alpha
8
integrin subunit beta
3
neurotrophic receptor
tyrosine kinase 3
insulin like growth
factor 1
matrix
metallopeptidase 2
matrix
metallopeptidase 12
angiotensin
converting enzyme 2
ADAM
metallopeptidase
with thrombospondin
type 1 motif 12
ADAM
metallopeptidase
with thrombospondin
type 1 motif 18
matrix
metallopeptidase 9
matrix
metallopeptidase 8
matrix
metallopeptidase 13
Kell metalloendopeptidase (Kell
blood group)

-0.985

1.46E-07

1.42E-06

-1.024

6.25E-07

5.42E-06

-1.039

1.47E-13

3.66E-12

-1.073

4.02E-11

7.13E-10

-1.127

7.56E-05

4.04E-04

-1.165

4.40E-15

1.39E-13

-1.243

1.34E-18

5.90E-17

-1.341

2.24E-21

1.32E-19

-1.447

6.32E-03

1.91E-02

-1.655

1.14E-29

1.31E-27

-1.839

2.24E-33

3.53E-31

-2.027

1.09E-02

3.04E-02

-3.001

2.35E-04

1.11E-03

-3.834

1.66E-06

1.31E-05

-4.8

3.58E-04

1.60E-03

-5.05

1.55E-05

9.75E-05
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Table 4: Axonal guidance molecules in 35 Male vs 125 Male group
GENE NAME

EXPR
LOG
RATIO

EXPR
PVALUE

padj

Wnt10A

Wnt family member 10A

2.74

1.23E-08

4.34E-07

Tuba8

tubulin alpha 8

2.128

3.34E-16

3.38E-14

Mmp12

matrix metallopeptidase 12

1.882

7.25E-03

4.20E-02

Bdnf

brain derived neurotrophic factor

1.739

6.12E-20

9.52E-18

Robo3

roundabout guidance receptor 3

1.501

3.44E-03

2.38E-02

Prkcg

protein kinase C gamma

1.356

1.79E-10

8.81E-09

Pak3

p21 (RAC1) activated kinase 3

1.272

2.20E-06

4.73E-05

Wnt6

1.077

3.03E-03

2.15E-02

1.036

1.22E-05

2.17E-04

Rnd1

Wnt family member 6
leucine rich repeat and Ig domain
containing 1
Rho family GTPase 1

0.845

6.65E-04

6.27E-03

Itgb6

integrin subunit beta 6

0.769

9.87E-05

1.30E-03

Vegfb

vascular endothelial growth factor B

0.731

9.53E-15

8.12E-13

Epha1

EPH receptor A1

0.686

5.42E-04

5.34E-03

Plcl1

phospholipase C like 1 (inactive)

0.679

4.47E-05

6.59E-04

Prkcb

protein kinase C beta

0.642

1.14E-04

1.47E-03

Bmp6

bone morphogenetic protein 6

0.576

4.34E-04

4.46E-03

Pak1

p21 (RAC1) activated kinase 1

0.568

1.39E-04

1.74E-03

Sema6C

semaphorin 6C

0.545

3.01E-03

2.14E-02

Rras2

-0.517

3.50E-05

5.35E-04

-0.519

1.55E-04

1.91E-03

Myl12B

RAS related 2
actin related protein 23 complex
subunit 5
myosin light chain 12B

-0.526

1.38E-04

1.73E-03

Gng5

G protein subunit gamma 5

-0.536

4.06E-03

2.71E-02

Nfatc4

nuclear factor of activated T cells 4

-0.562

1.55E-03

1.26E-02

Pdgfc

platelet derived growth factor C

-0.562

8.90E-03

4.92E-02

Bmp1

bone morphogenetic protein 1

-0.581

1.04E-03

9.17E-03

Rac2

Rac family small GTPase 2

-0.587

5.85E-05

8.32E-04

Prkd3

protein kinase D3

-0.594

2.39E-03

1.78E-02

Tubb2A

tubulin beta 2A class IIa

-0.596

4.62E-05

6.77E-04

Gna14

G protein subunit alpha 14

-0.6

6.15E-05

8.69E-04

Efnb3

ephrin B3

-0.636

7.99E-03

4.53E-02

Fzd9

frizzled class receptor 9
neurotrophic receptor tyrosine
kinase 2
integrin subunit alpha 5

-0.682

4.65E-03

3.00E-02

-0.796

2.68E-04

2.97E-03

-0.809

3.38E-04

3.62E-03

-0.815

1.28E-03

1.08E-02

-0.841

3.20E-03

2.25E-02

Mmp14

plexin D1
ADAM metallopeptidase with
thrombospondin type 1 motif 9
matrix metallopeptidase 14

-0.864

5.50E-04

5.40E-03

Plcl2

phospholipase C like 2

-0.887

1.72E-18

2.23E-16

Symbol

Lingo1

Arpc5

Ntrk2
Itga5
Plxnd1
Adamts9
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Robo2

roundabout guidance receptor 2

-0.907

1.87E-07

5.36E-06

Gnb4

-0.927

6.73E-06

1.28E-04

-0.959

4.80E-07

1.26E-05

Unc5B

G protein subunit beta 4
ADAM metallopeptidase with
thrombospondin type 1 motif 2
unc-5 netrin receptor B

-1.033

9.48E-04

8.47E-03

Wnt4

Wnt family member 4

-1.042

1.53E-06

3.47E-05

Adam19

ADAM metallopeptidase domain 19

-1.055

2.39E-05

3.87E-04

Itgb3

integrin subunit beta 3

-1.058

7.52E-03

4.33E-02

Fzd8

frizzled class receptor 8

-1.097

3.08E-03

2.18E-02

Mmp9

matrix metallopeptidase 9

-1.121

5.61E-03

3.42E-02

Efna1

ephrin A1

-1.132

1.45E-06

3.31E-05

Igf1

insulin like growth factor 1

-1.189

3.15E-09

1.28E-07

Itga8

integrin subunit alpha 8

-1.223

4.24E-09

1.67E-07

Bmp15

-1.227

7.18E-04

6.68E-03

-1.229

6.22E-05

8.77E-04

Rtn4R

bone morphogenetic protein 15
neurotrophic receptor tyrosine
kinase 3
reticulon 4 receptor

-1.231

1.25E-03

1.06E-02

Cxcr4

C-X-C motif chemokine receptor 4

-1.276

8.76E-18

1.06E-15

Pgf

placental growth factor

-1.279

9.70E-07

2.33E-05

Gli1

GLI family zinc finger 1

-1.338

1.13E-06

2.69E-05

Mmp2

matrix metallopeptidase 2
ADAM metallopeptidase with
thrombospondin type 1 motif 7
integrin subunit alpha 10
ADAM metallopeptidase with
thrombospondin type 1 motif 12
angiotensin converting enzyme 2

-1.394

2.69E-11

1.49E-09

-1.4

1.36E-14

1.14E-12

-1.527

2.65E-04

2.95E-03

-1.704

3.99E-09

1.59E-07

-1.923

6.34E-20

9.74E-18

matrix metallopeptidase 8
ADAM metallopeptidase with
thrombospondin type 1 motif 18
myelin associated glycoprotein

-2.37

1.93E-03

1.50E-02

-2.666

1.01E-04

1.32E-03

-3.145

1.19E-04

1.52E-03

matrix metallopeptidase 13
Kell metallo-endopeptidase (Kell
blood group)

-4.157

1.63E-05

2.78E-04

-5.35

7.46E-07

1.85E-05

Adamts2

Ntrk3

Adamts7
Itga10
Adamts12
Ace2
Mmp8
Adamts18
Mag
Mmp13
Kel
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Table 5: Inflammatory signaling pathway genes differentially expressed
between 35 day-old and 125 day-olds in females
Symbol
Hla-A
Prkcg
Tlr8
Hla-Drb5
Gabra1
Calb1
Gabra3
S100G
Grin2A
Bdnf
Gabrb2
Il6R
Kcnj6
Gabrr1
Mapt
Gabre
Kcnj9
Kcnj3
Slc6A13
Mapk11
Hla-E
Hla-G
Mapk12
Slc6A1
Irf3
Ikbke
Cd200
Gabrg2
Gabra4

GENE NAME
major histocompatibility complex,
class I, A
protein kinase C gamma
toll like receptor 8
major histocompatibility complex,
class II, DR beta 5
gamma-aminobutyric acid type A
receptor subunit alpha1
calbindin 1
gamma-aminobutyric acid type A
receptor subunit alpha3
S100 calcium binding protein G
glutamate ionotropic receptor
NMDA type subunit 2A
brain derived neurotrophic factor
gamma-aminobutyric acid type A
receptor subunit beta2
interleukin 6 receptor
potassium inwardly rectifying
channel subfamily J member 6
gamma-aminobutyric acid type A
receptor subunit rho1
microtubule associated protein
tau
gamma-aminobutyric acid type A
receptor subunit epsilon
potassium inwardly rectifying
channel subfamily J member 9
potassium inwardly rectifying
channel subfamily J member 3
solute carrier family 6 member
13
mitogen-activated protein kinase
11
major histocompatibility complex,
class I, E
major histocompatibility complex,
class I, G
mitogen-activated protein kinase
12
solute carrier family 6 member 1
interferon regulatory factor 3
inhibitor of nuclear factor kappa
B kinase subunit epsilon
CD200 molecule
gamma-aminobutyric acid type A
receptor subunit gamma2
gamma-aminobutyric acid type A
receptor subunit alpha4
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EXPR LOG
RATIO

EXPR PVALUE

PADJ

4.508

6.95E-03

2.07E-02

1.638

1.10E-21

6.68E-20

1.549

2.02E-14

5.71E-13

1.541

2.11E-04

1.00E-03

1.456

2.15E-12

4.53E-11

1.254

8.07E-20

4.00E-18

1.131

5.35E-22

3.35E-20

1.08

3.02E-12

6.31E-11

1.062

3.95E-04

1.74E-03

0.984

1.55E-03

5.71E-03

0.984

1.23E-03

4.66E-03

0.961

1.09E-25

8.81E-24

0.944

4.51E-15

1.42E-13

0.852

5.51E-05

3.04E-04

0.801

1.83E-34

3.12E-32

0.786

1.88E-11

3.53E-10

0.782

2.21E-11

4.08E-10

0.772

2.37E-07

2.23E-06

0.748

6.63E-05

3.59E-04

0.722

8.70E-04

3.43E-03

0.719

1.31E-16

4.75E-15

0.684

1.03E-21

6.28E-20

0.67

6.58E-09

8.30E-08

0.667

4.33E-12

8.84E-11

0.623

8.00E-16

2.70E-14

0.614

6.29E-06

4.34E-05

0.606

5.38E-11

9.39E-10

0.606

1.75E-11

3.30E-10

0.589

5.15E-04

2.18E-03

Kcnj5

potassium inwardly rectifying
channel subfamily J member 5
glutamate ionotropic receptor
AMPA type subunit 1
BCL2 apoptosis regulator

0.586

1.77E-02

4.55E-02

0.557

5.25E-12

1.06E-10

0.539

1.03E-04

5.32E-04

-0.532

2.35E-05

1.42E-04

-0.546

4.86E-04

2.08E-03

Tgfb3

interleukin 1 receptor type 1
spleen associated tyrosine
kinase
transforming growth factor beta 3

-0.57

7.26E-09

9.07E-08

Ifngr1

interferon gamma receptor 1

-0.571

6.66E-16

2.26E-14

Tgfb2

transforming growth factor beta 2

-0.586

4.10E-05

2.34E-04

Tlr6

toll like receptor 6

-0.6

1.55E-04

7.65E-04

Tgfb1

transforming growth factor beta 1

-0.604

8.74E-05

4.60E-04

Cd40

CD40 molecule

-0.615

1.81E-02

4.64E-02

Casp3

caspase 3
PYD and CARD domain
containing
transmembrane immune
signaling adaptor TYROBP
solute carrier family 6-member
11
cAMP responsive element
binding protein 5
Rac family small GTPase 2

-0.62

7.63E-12

1.52E-10

-0.648

5.08E-04

2.16E-03

-0.686

2.10E-08

2.38E-07

-0.754

2.56E-04

1.19E-03

-0.764

3.91E-03

1.27E-02

-0.768

8.74E-08

8.88E-07

solute carrier family 1 member 2
phosphoinositide-3-kinase
regulatory subunit 1
gamma-aminobutyric acid type A
receptor subunit pi
vascular cell adhesion molecule
1
phospholipase A2 group IVA

-0.768

1.07E-03

4.12E-03

-0.87

6.15E-29

6.54E-27

-0.893

1.74E-02

4.48E-02

-0.903

1.78E-28

1.80E-26

-1.021

3.09E-10

4.84E-09

S100 calcium binding protein B
glutamate ionotropic receptor
NMDA type subunit 2B
prostaglandin-endoperoxide
synthase 2
gamma-aminobutyric acid type A
receptor subunit gamma3
glutamate decarboxylase 1

-1.252

3.37E-37

6.49E-35

-1.262

1.05E-02

2.93E-02

-1.289

1.27E-02

3.47E-02

-1.61

1.88E-04

9.07E-04

-1.753

5.27E-07

4.61E-06

NADPH oxidase 4
gamma-aminobutyric acid type A
receptor subunit delta
C-X-C motif chemokine ligand 10
baculoviral IAP repeat containing
5
matrix metallopeptidase 9

-1.759

3.41E-06

2.50E-05

-2.186

1.64E-04

8.05E-04

-2.542

6.12E-08

6.39E-07

-2.919

3.82E-22

2.42E-20

-3.001

2.35E-04

1.11E-03

Gria1
Bcl2
Il1R1
Syk

Pycard
Tyrobp
Slc6A11
Creb5
Rac2
Slc1A2
Pik3R1
Gabrp
Vcam1
Pla2G4A
S100B
Grin2B
Ptgs2
Gabrg3
Gad1
Nox4
Gabrd
Cxcl10
Birc5
Mmp9
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Table 6: Inflammatory signaling pathway genes differentially expressed
between 35 day-old and 125 day-olds in males
Symbol
Hla-A
Hla-Drb5
Fos
Bdnf
Gabra3
Il6R
Grin2A
Calb1
Hla-Dra
Prkcg
Gabrb2
Hla-Dqa1
Mapt
Gabre
Bcl2
Cd200
Gabra2
Hla-E
Irak2
Il18
Mapk12
S100G
Gabrb1
Kcnj5
Gabrg2
Gabra4
Grin1
Pla2G6
Kcnj9
Mfge8

GENE NAME
major histocompatibility
complex, class I, A
major histocompatibility
complex, class II, DR beta 5
Fos proto-oncogene, AP-1
transcription factor subunit
brain derived neurotrophic factor
gamma-aminobutyric acid type
A receptor subunit alpha3
interleukin 6 receptor
glutamate ionotropic receptor
NMDA type subunit 2A
calbindin 1
major histocompatibility
complex, class II, DR alpha
protein kinase C gamma
gamma-aminobutyric acid type
A receptor subunit beta2
major histocompatibility
complex, class II, DQ alpha 1
microtubule associated protein
tau
gamma-aminobutyric acid type
A receptor subunit epsilon
BCL2 apoptosis regulator
CD200 molecule
gamma-aminobutyric acid type
A receptor subunit alpha2
major histocompatibility
complex, class I, E
interleukin 1 receptor associated
kinase 2
interleukin 18
mitogen-activated protein kinase
12
S100 calcium binding protein G
gamma-aminobutyric acid type
A receptor subunit beta1
potassium inwardly rectifying
channel subfamily J member 5
gamma-aminobutyric acid type
A receptor subunit gamma2
gamma-aminobutyric acid type
A receptor subunit alpha4
glutamate ionotropic receptor
NMDA type subunit 1
phospholipase A2 group VI
potassium inwardly rectifying
channel subfamily J member 9
milk fat globule EGF and factor
VVIII domain containing
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Exp
Log
Ratio

P value

3.033

1.14E-05

2.05E-04

1.981

4.13E-12

2.61E-10

1.949

2.91E-03

2.08E-02

1.739

6.12E-20

9.52E-18

1.624

3.47E-10

1.66E-08

1.575

8.41E-39

4.40E-36

1.47

1.52E-03

1.24E-02

1.439

8.91E-15

7.64E-13

1.426

1.14E-11

6.67E-10

1.356

1.79E-10

8.81E-09

1.116

7.60E-03

4.36E-02

1.087

1.65E-04

2.02E-03

1.068

5.02E-10

2.33E-08

0.996

6.17E-04

5.92E-03

0.913

9.60E-04

8.56E-03

0.877

1.26E-21

2.28E-19

0.867

2.70E-03

1.96E-02

0.829

1.78E-12

1.16E-10

0.817

1.19E-09

5.19E-08

0.816

1.80E-06

3.95E-05

0.806

2.12E-04

2.46E-03

0.797

8.55E-03

4.77E-02

0.789

1.16E-05

2.07E-04

0.777

3.72E-09

1.50E-07

0.765

3.49E-07

9.40E-06

0.59

2.90E-03

2.08E-02

0.564

1.78E-04

2.15E-03

0.561

7.95E-06

1.49E-04

0.524

1.85E-03

1.45E-02

0.511

1.53E-03

1.25E-02

padj

Grin3B

glutamate ionotropic receptor
NMDA type subunit 3B
interferon gamma receptor 1

0.503

6.46E-05

9.03E-04

-0.535

2.13E-07

6.04E-06

phospholipase A2 group V
nuclear factor of activated T
cells 4
Rac family small GTPase 2

-0.537

1.24E-03

1.06E-02

-0.562

1.55E-03

1.26E-02

-0.587

5.85E-05

8.32E-04

caspase 3
transforming growth factor beta
2
cAMP responsive element
binding protein 5
solute carrier family 6 member
11
phospholipase A2 group IVA

-0.742

1.76E-07

5.11E-06

-0.891

5.36E-05

7.74E-04

-0.942

5.53E-03

3.39E-02

-0.97

8.74E-03

4.86E-02

-0.995

1.93E-06

4.19E-05

Gad1

glutamate decarboxylase 1

-1.014

4.25E-03

2.81E-02

Cd40

CD40 molecule
vascular cell adhesion molecule
1
matrix metallopeptidase 9

-1.024

3.66E-04

3.88E-03

-1.082

1.10E-08

3.94E-07

-1.121

5.61E-03

3.42E-02

kallikrein 1

-1.146

9.34E-04

8.37E-03

S100 calcium binding protein B
glutamate ionotropic receptor
NMDA type subunit 2B
phospholipase A2 group IIF

-1.39

4.19E-22

8.01E-20

-2.043

7.69E-04

7.09E-03

-2.063

3.40E-06

6.97E-05

NADPH oxidase 4
baculoviral IAP repeat
containing 5
gamma-aminobutyric acid type
A receptor subunit delta

-2.139

1.28E-09

5.56E-08

-2.669

1.70E-15

1.56E-13

-3.101

7.72E-11

3.96E-09

Ifngr1
Pla2G5
Nfatc4
Rac2
Casp3
Tgfb2
Creb5
Slc6A11
Pla2G4A

Vcam1
Mmp9
Klk1
S100B
Grin2B
Pla2G2F
Nox4
Birc5
Gabrd
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As stated before, there were 1079 significantly expressed genes
between M and F at 125 days old compared to 24 SigDEGs at 35 days old.
Figure 14 shows the top canonical enriched pathways in males and females
at 125 days old. The canonical pathways do not show inflammatory signaling
pathway or axonal guidance signaling pathway among the most significant
enriched pathways.

Figure 14. Top canonical pathway enriched between M and F at 125 days
old.
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RT-qPCR Analysis
Selected genes were used to validate the RNA sequencing data
through the RT-q PCR, which starts with conversion of RNAs to cDNA then
amplification of cDNA using PCR and finally detection and quantification of
PCR product in real time. Bdnf, Vgf, Oxt, S100b, Gfap, RtI-a2, Sox11, Rt1m3, Tapbp and Actb gene as a reference gene were used in the experiment.
Real time-qPCR quantification data was then used to calculate 2 -∆∆ct value
which infer the relative change in gene expression, a convenient method to
express the fold change in gene expression between the control and group of
interest, as explained in the method section. A table showing the 2 -∆∆ct for all
genes that were finally selected in the RT-qPCR in each group is shown in
(APPENDIX I), we excluded Vgf from the list as most of the wells did not
show any Ct values and the minimum Ct value that appeared for other
replicate was 35, which could implicate suboptimal PCR efficiency. According
to the MIQE guidelines (Bustin et al. 2009), a Ct value of 40 is used as cutoff,
any Ct value >40 generally should not be reported, which could explain why
some wells were missing Ct values. An amplification factor of 2 reflects a
100% qPCR efficiency and means that all original transcripts were doubled
every cycle, and its determined based on the slope of log linear portion of
amplification curve. For most genes included in the study, except for Vgf, the
reactions showed comparable efficiencies.
Statistical Analysis
Statistical analysis was performed using the Qbase+ software.
Calculation parameters included normalization to a reference target gene
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(ACTB) and scaling to a control group, the program automatically
determines the suitable test according to the experiment and samples
properties. Analysis was performed using unpaired T test and allowed to
correct for multiple testing. A table (APPENDIX I) shows log2FC and P values
from qPCR experiment. Pearson correlation(r) was implemented to examine
the concordance between RNA seq gene expression data and RT-PCR gene
expression of selected genes. The coefficient of determination(r2) is 0.33
which would mean that Pearson correlation coefficient of r=0.57, indicating a
positive correlation between the two variables (RNA seq log FC and qPCR log
FC), the percentage of variance shared between these two variables is 33%
and 60% of the RNA seq log FC and qPCR log FC data can be explained by
the linear model.
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15-a

15-b

15-c

15-d
Bdnf /M

Bdnf/F

Gfap/M

Gfap/F
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Oxt /M

Oxt/F

RT1-A2 /M

RT1-A2 /F

RT1-M3 /M

RT1-M3 /F

S100β/F

S100β/ /M

Sox11 /M

Sox11 /F
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Tapbp /M

Tapbp /F

Figure 15. Pearson correlation between RNA seq and qPCR experiment.
Figure (15-a) shows the correlation between log2FC of RNA seq and qPCR.
Blue dots show selected genes from each group with a R2 =0.325. 15-b is a
chart of all selected genes and groups. Genes with bars pointing in the same
direction of the chart correspond to each other in terms of expression such as
Bdnf, Rt1-a, Rt1-m3and Tapbp. Blue bars represent qPCRlog2FC. Orange
bars represent RNAseqlog2FC. (15- c) are the bar chart that represent the
relative quantities of all selected genes in the male group compared to bar
charts in (15-d) which represent genes from the female group from qPCR. In
each bar graph, the left bar refers the change in gene expression in 125 day
old and the right bar refers to gene expression change in 35 day old.
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CHAPTER IV
DISCUSSION
RNA sequencing is a powerful tool for obtaining quantitative
information about the RNA population in any cell or tissue. In this study we
utilized the available RNA sequencing tools to compare the transcriptome of
young (35 day old) vs mature (125 day old) neuronal processes and glial cells
in the rat neurohypophysis. The neurohypophysis provides a model system
that contributed to our understanding of the axonal regeneration in the CNS
that has been proven in earlier studies. Partial axotomy of hypothalamicneurohypophysis tract extending from hypothalamic SON to reach the
terminal field, the neural lobe, leads to reinnervation of the NL by contralateral
SON, and that the sprouting response seen at 35 days old was dramatically
reduced at 125 days old (Watt et al. 1991,1999, 2006, 2009). Proven axonal
regeneration in the CNS in animal model was a great step forward toward
understanding CNS plasticity; however, the process and mechanisms are still
elusive.
Axonal outgrowth and regeneration require carefully orchestrated
intrinsic and extrinsic factors to allow for pro-growth molecules to be turned on
and inhibitory factors to be tuned down, meaning that changes in certain gene
expression, temporally and spatially, could be an ideal explanation for
regulating these factors that impact the axonal response whether post injury
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or even in the context of normal aging. At the molecular level, it's been known
for a while that peripheral axonal injury and partial injury in the immature CNS
is associated with a robust activation of regeneration transcription programs,
but we still do not have evidence of such a similar response in the mature
CNS (Lindner et al. 2013). Therefore, it is plausible to consider epigenetic
changes that affect gene expression regulation without the need to alter the
DNA itself as reasonable hypothesis to explain the robust change in CNS
plasticity during the maturational process.
Studies from spinal cord injury models (SCI) and dorsal root ganglion
(DRG) and retina have shown that neurons that have the intrinsic
regeneration program can display a regeneration associated gene (RAG)
response. The RAG response consists of changes in expression of genes and
transcription factors (TF) (Fagoe et al. 2014, Tedeschi et al 2019). Microarray
studies and RNA seq studies have contributed to identifying several RAG
genes and TFs using different model systems. In this study we investigated
the changes in gene expression of many of the previously identified RAG
genes and TFs.
Since we chose to use the neural lobe in this study, we need to
address the diverse cellular components that also contribute to changes in
gene expression. The MCNs axonal tracts compromise approximately 50% of
the NL tissue (Burbach et al. 2001). 30 % of the remaining cellular volume is
comprised of the resident GFAP-ir pituicytes, this percentage could reach up
to 70 % near the basal lamina (Hatton. 2009). Another cellular phenotype is
the parenchymal microglia, which compromises about 5% of the cell
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population. Morphometry studies of rat neurohypophysis estimates the
volume of neurohypophysis occupied by blood vessel and endothelial cells to
be approximately 7% (Nordmann.1977). Consequently, all these cellular
populations are expected to contribute to the RNA pool expressed in the NL.
Specific cell-type markers are used to identify these cells as they are known
to be exclusively specific to one cell type. However, for most of the RNAs
sampled in the NL transcriptome, identification of the specific cellular
phenotype contribution to the expression changes will require the use of
additional complementary methods such as single qPCR and in situ
hybridization.
Changes in Gene Expression of Specific Cellular Marker in the NL
Table 7 shows the changes in gene expression of selected cell-type
markers from an analysis of RNA seq data obtained comparing 35-day old
male and female samples vs 125-day old male and female samples. The
presence of Avp and Oxt mRNAs in the neural lobe of rat pituitary has been
described before in many studies but the question about their cellular origin,
physiological function and regulation in the NL remains controversial. Studies
on rat neurohypophysis have shown that the length of Avp and Oxt mRNAs
poly (A) tail increases following an osmotic stimulus in the SON, however, the
reason behind this poly tail length shift is not identified yet, but it has been
suggested to affect the transcript stability and reflect on the efficiency of
translation. On the other hand, following an osmotic stimulus, pituitary Avp
and Oxt mRNAs levels increased but their poly (A) tail lengths were shorter
and did not change compared to their hypothalamic counterparts. Two
different possible explanations emerged to explain the cellular origin of the
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observed pituitary mRNAs: The first hypothesis that attempted to explain this
presence, was the axonal anterograde transport of the mRNAs to the axon
terminals, which is supported by the demonstration of VP mRNA in axonal
swellings in the median eminence (Mhor et al.1991, Pu l et al.1995, Burbach
et al. 2001). These data suggest that these mRNAs may serve as signaling
molecules between the cell perikarya and axon terminals, a mechanism that
requires the hypothalamic mRNAs to undergo poly (A) shortening during the
transfer. The second hypothesis behind this phenomenon is the local
synthesis in the pituitary which is supported by the detection of Avp mRNAs
immunoreactivity in a subset of pituicytes of pituitary stalk transected rats
after osmotic stimulation (Pu et al.1995). However, it is not clear whether
these transcripts originate in the pituicytes or transferred from axon terminals
to pituicytes.
Another magnocellular neuron specific cell marker is the Vgf, an
inducible gene, that is highly sensitive to nerve growth factor (NGF) and brain
derived growth factor (Bdnf). Vgf immunoreactivity was reported in the
pituitary posterior lobe (Ferri and Poseenti. 1996). Colocalization with Avp and
Oxt was demonstrated in magnocellular neurons in rat SON and PVN (Van
den Pal et al. 1989). In retinal ganglion cells, Vgf peptide was located in glial
cells following optic nerve crush injury and it was found to promote neurite
outgrowth in rat retinal ganglion cells (Takeuchi et al. 2018).
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Table 7: Relative expression of cell-type specific markers in the NL
samples
Phenotype

pvalue

padj

0.768942

1.27E-08

1.56E-07

1340.4709

-0.45953

0.04128

0.093516

Vgf

215.74194

-1.404144

0.0004

0.001822

Gfap

1359.7794

-1.358887

6.72E-24

4.40E-22

S100b

3572.7776

-1.326658

7.03E-52

1.49E-49

Tmem119

288.94763

-1.241322

8.66E-19

3.73E-17

Cd40

44.630803

-0.825513

2.64E-06

2.05E-05

Arg1

341.865493

-1.090486

8.28E-26

6.11E-24

Blood vessels

Pecam1*

1079.3134

-0.902018

2.02E-09

2.86E-08

Neurons

Gap43**

1097.72

0.847301

6.02E-15

1.76E-13

Nefm

216.08983

0.536912

0.004

0.01203

MCNs

Astrocytes
Microglia

[1]

gene symbol

baseMean [1]

Oxt

2215.8682

Avp

log2FC

RNA seq analysis was performed by pooling male and female samples

from 35-day old and samples from male and female (4 replicates from each
group) at 125-day old together. Base means represent the expression
intensity (total number of reads) of the gene from pooled samples.
*Pecam1, also known as CD31, is a platelet/endothelium cell adhesion
molecule-1 and its highly expressed on endothelial cells (Goncharov et al.
2017)
** (Gap43) is a neuron-specific phosphoprotein, which plays critical role in
axon growth and synapses functions during neurogenesis
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It’s also apparent from Table 7 that there is a general decline in the
gene expression of biological markers of the glial cells. S100b and Gfap are
commonly used specific markers for pituicytes. The parenchymatous
pituicytes were found to be stained with antibodies against both Gfap and
s100b, whereas the fibrous pituicytes were only immunoreactive to S100b
antibodies (Xiao-Yan Wei et al. 2009).
The general function of the microglia in the CNS is to monitor the
environment and start an inflammatory response to maintain the homeostasis,
which makes them the first line of defense in the adult brain. Once these cells
recognize a pathogen or micro changes in the environment resulting from
other forms of diseases, such as chemokines receptor changes, pathogen
fragments, or Toll like receptor (TLR) or change in adhesion molecules levels,
they will become activated and release cytokines to alert the surrounding cells
such as glial cells. There is a variety of markers that can be used to detect the
microglia in the CNS, such as Transmembrane protein 119 (TMEM 119),
purinergic receptor protein (P2Y12R), cluster differentiation proteins, major
histocompatibility complex II and others (Jurga et al. 2020). Some of these
markers are present during the resting state and others are associated with
activated state such as cluster differentiation 40 (CD40), a tumor necrosis
factor receptor 5, shown in Table 7. Type I arginase (Arg1), another
intercellular activated state marker of microglia, had been identified as a RAG
gene, is showing a downregulation (Tables 7/8). TMEM119, the most specific
general microglia markers, and CD40 (Table 7) genes are showing a down
regulation as well. Tables (5/6) shows a decline in metalloprotease 9 (MMP9),
an extracellular enzyme that regulates the bioavailability of chemokines and
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cytokines during inflammation. However, we can see upregulation of genes
that promotes the proinflammatory response. Microglia are antigen presenting
cells that use MHC II complex for antigen presentation, genes such as HLA-A,
HLA-drb5, ILR6 are upregulated as shown in Tables (5/6) and they reflect a
state of neuroinflammtory response in the brain. Aging is one of the important
factors that influence microglia activation and markers expression, especially
if they were exposed to different episodes of activations and inflammatory
responses during their life span, which makes them more responsive
permanently (Jurga et al. 2020). Growth associated protein 43 (GAP43) is a
neuron specific phosphoprotein and one of the first RAGs to identified, it was
found to be expressed in successfully regenerating systems such as after
injury of peripheral DRG axons. GAP43 overexpression, along with GAP23
helped inducing a long-distance regeneration of spinal cord axons into nerve
graft after spinal cord injury and it was found to enhance sprouting, but not
long-distance regeneration, in the CNS (Fagoe et al. 2014). Table 7 shown an
upregulation of this RAG gene, which is not sufficient to induce a robust
regeneration response in the CNS. It is becoming clear why we need a more
complete understanding of the RAG response in the NL.
Change in Gene Expression of RAG Genes and Transcription Factors in
the Neural Lobe of the Maturing Rat
A considerable amount of effort has been directed to identify the genes
that have been known to be play a role in the axonal regeneration in the PNS
and other model systems. A sufficient number of studies have yielded a road
map of several genes and transcription factors that contribute in different
ways to the regeneration associated transcription response post-injury, but we
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are still far away from identifying specifically which genes or TFs are part of
regeneration response after injury and in response to other triggers that
changes the homeostasis of the CNS including aging. We still do not know
how these known RAG genes and TFs impact the regeneration process,
whether they affect the initiation of growth cone outgrowth, elongation, turning
of the growth cone or the environmental milieu that navigate the axonal
outgrowth. However, all these studies suggest that a robust effect on the
regeneration response is not necessarily guaranteed by modulating a single
RAG gene or TF (MA T et al. 2015). A list of terminal RAGs included: a 7
integrin, BDNF, b2-microglobin, Cdc42, Galanin, Galectin-1, Gap43+CAP23,
GDNF, Hsp27, IL-6, PACAP, Rac1 and others. It is also important to mention
that the activation of cell signals that results from disrupted environment,
whether by locally transferred axonal factors or membrane depolarization of
plasma membrane and Ca2+ influx, results in elevated cAMP which drives the
initiation of regenerative response by activating the PKA pathway and
expressing TFs. Regeneration -associated transcription factors include but
not limited to ATF3, C/EBP delta, c-JUN, CREB, KLF7, p53, SMAD1, SnoN,
SOX11, STAT3. Table 8 shows a list of RAGs and TFs from our RNA seq
analysis and their log2FC.
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Table 8: Selected regenerative associated RAGs and TFs differentially
expressed between 35 day-old and 125 old-day (from both males and
females pooled together)
Gene
Symbol

BASE
MEAN

Atf3
Stat3

42.26336
4642.511

Sox11

128.522

Nfil3
Creb5

193.6242
33.21646

Arg1

341.8655

Gap43
Bdnf

1097.72
516.1642

Vgf

215.7419

LOG2FC

P VALUE PADJ

CATEGORY

0.743409
0.139897
0.959788
1.070368
-0.85417
1.090486
0.847301
1.367292
1.404144

0.001385
0.00473

0.005466
0.015443

TF
TF

1.36E-10

2.35E-09

TF

0.009067
3.75E-05

0.026542
0.000223

TF
TF

8.28E-26

6.11E-24

RAG

6.02E-15
5.45E-14

1.76E-13
1.42E-12

RAG
RAG

0.000393

0.001822

RAG

Based on Table 8, we can see the upregulation of GAP43 and Bdnf,
both are RAG genes that have shown before to be activated by complex
formation between the histone acetyltransferase p300 and the histone
acetyltransferase 1 p300/CBP associated factor (PCAF) in PNS injury,
indicating that epigenetic changes may play a role in the regulation of RAG
response and axonal regeneration (Puttagunta et al. 2014) (Fagoe et al.
2014). It is necessary to identify the changes in expression of RAG genes and
TF in the maturing NL, to be able to study epigenetic changes that may
influence the neuronal plasticity in the maturing rat brain.
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Neuroinflammatory Signaling Pathway
Studies have shown that aging astrocytes lose their ability to perform
their normal functions as they take on a reactive phenotype of
neuroinflammatory A1-like reactive astrocytes (Clarke et al. 2017). Ingenuity
pathway analysis in Figure (113a/b) show the neuroinflammatory signaling
pathway significant enrichment. Table 5 and 6 shows a list of upregulated and
downregulated molecules in this pathway. A list of reactive astrocytes
associated genes that are activated in response to the presence of different
cytokines such as IL-1a, TNF and C1q is shown in Table 9. These genes
include those involved in complement pathway, cytokine pathway and antigen
presentation. The biological significance of the activation of the inflammatory
pathway is that it could go beyond protecting the brain tissue and maintain the
homeostasis to overwhelming the astrocytes by inducing the reactivity that
may impact their ability to perform their normal functions.
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Table 9: Reactive astrocytes associated genes differentially expressed
between 35 days old and 125 days old
Gene
baseMe log2FoldC pvalue
padj
category
symbol an
hange
Serpina3n

6.9346

-2.25784261

0.00064633

0.00281648

9
C4b

45.468

C3

2034.79

Cxcl10
Gfap

115.773
1359.77

1.112369917
0.683901816
-1.575788624
-1.358886731

3.95E-05

peptidase
inhibitor

0.00023376

complement

8

pathway

0.00018346

complement

1

cascade

0.00019453

0.00097040

cytokine

2

4

6.72E-24

4.40E-22

3.00E-05

astrocyte
marker

C1qa
IL-1a

1435.02
6.62869

-0.035698663
1.334803664

0.81051716

0.88086774

A1 astrocytes

6

6

inducer

0.00552389

0.01760681

cytokine

6

6

Axonal Guidance Signaling Pathway
It’s been known that axonal guidance cues, whether attractive or
repulsive, and receptors play a major role in the development of neural
circuits not only during the initiation phase of growth cone but also in the
motility and navigation of growth cone; they also impact the gene expression
of axonal guidance genes. The best example is BDNF, which an attractive
axonal guidance molecule that can coordinate the axonal guidance by
changing mRNAs expression and local translation of RNA binding protein
(Kim SK and Kim KT et al. 2020). Axonal guidance molecules and receptors
include neurotrophic factors, slit, netrins, semaphorins (SEMA3b, SEMA5a),
ephrin, and roundabout (Robo-2/3). Members of the two the families of
metalloproteases, the A-Disintegrin and metalloprotease (ADAM) family and
matrix metalloproteases (MMPs) family, are also differentially expressed and
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studies suggest that these proteases are necessary for axonal pathfinding as
they help cleave and chew the ECM to clear the way for extending axons,
however, more studies are needed to investigate the individual members of
both families to identify their specific role and contribution (McFarlane. 2003).
The list in Table 3 and Table 4 also include some non-conventional axonal
guidance cues such as Wnt family members, bone morphogenic protiens
(BMPs). Studies have shown that BMPs, the largest subfamily of transforming
growth factor (TGF-b), regulate the number, branching and length of neurites
in developing neuronal circuits, and they also have a role in promoting growth
cone axonal guidance and orientation (Gamez. 2013). However, other studies
suggested an inhibitory role of BMP-4 on the axonal growth (Matsuura et al.
2008) (Engelhard et al. 2013). Wnt family members especially wnt3, was
suggested to start the early stages of neuronal polarity when they locally
accumulate, creating a Wnt gradient that allows for the microtubules
reorganization and determine the polarity of neuronal cells. The role of Wnt in
early stages of neuronal development create an interesting biological question
about the specific role of other family members in axonal guidance
(Stanganello et al. 2019). Insulin like growth factor IGF-1 is emerging as a
crucial molecule that many studies suggested as a neuroprotective and
regeneration associated molecule post injury in the CNS as well as its role in
maturation and CNS plasticity (Dyer et al. 2016).
Concluding Remarks and Future Direction
In this study we aimed to investigate the changes in transcriptome
between 35 day old and 125 day old magnocellular neurons and glia in the NL
of maturing rat, to provide a base knowledge of the changes in gene
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expression of a previously proven model of regeneration in the CNS. Our
findings indicate that along with changes in gene expression of many axonal
guidance genes that contribute to the initiation and navigation of growth cone
in the NL, there is an inflammatory response that is happening in the context
of maturing neurons and glia. We were able to identify expression changes in
some of the previously known regeneration associated genes and
transcription factors, which is necessary step to further understand epigenetic
mechanisms responsible for initiating and maintain a RAG response. Our
findings are only a primary step in identifying the maturational induced
changes in the epigenetic landscape that lead to age associated loss of
neuronal plasticity. However, one of the obstacles that we faced in this study,
is the inability to identify the specific contribution of each cellular phenotype to
the changes in gene expression in the maturing NL.
To ensure our complete understanding of the epigenetic landscape of
NL, we need to further investigate the specific contribution of MCNs and glia
in the NL and characterize the maturational alteration that contribute to
chromatin changes and accessibility to RAG genes. We also need to validate
the changes in gene expression and further characterize the biological
significance of genes of interest in the axonal regeneration. In this study, we
have identified changes in gene expression of regeneration associated genes
and transcription factors, however, we need to ensure that these changes in
gene expression are also associated with changes in protein levels. Enzyme
Linked Immunosorbent Assay (ELISA) is a quantitative as well as qualitative
assay that can be used to quantify the protein level associated with each
gene of interest. From our findings we were able to narrow down the list
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genes of interest to be further validated using a protein assay. Candidate
genes include regeneration associated genes such as Bdnf, Vgf and Gap43,
and genes overrepresented in axonal guidance signaling pathway and
neuroinflammatory pathway. Identifying biologically significant regulators in
axonal reaeration is necessary to understand the downstream signaling
mediated by these regulators or affected by the changes they embark on
other regulatory mechanisms of regeneration program.
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APPENDIX I
Raw Data Phred Sores
Sample ID

Total Read

Total

Bases(bp)

Reads

N(%)

GC(%)

Q20(%)

Q30(%)

G2020_97_1

11011721810

72925310

0.0142

48.9

97.82

94.57

G2020_97_2

12849288224

85094624

0.0142

49.5

97.65

94.21

G2020_97_3

12803347078

84790378

0.0142

50.25

97.51

93.96

G2020_97_4

22934209482

151882182

0.014

50.26

97.58

94.03

G2020_97_5

11316044794

74940694

0.0142

49.96

97.52

93.94

G2020_97_6

13809247470

91451970

0.0139

50.25

97.6

94.06

G2020_97_7

11585618148

76725948

0.0141

50.3

97.46

93.78

G2020_97_8

13321441668

88221468

0.0143

49.9

97.73

94.36

G2020_97_9

14022744256

92865856

0.0142

50.68

97.7

94.29

14105590104

93414504

0.0141

50.67

97.46

93.81

11071465866

73320966

0.0141

50.93

97.41

93.7

14474608736

95858336

0.014

51.28

97.51

93.87

8516502076

56400676

0.0141

50.26

97.46

93.87

11166658682

73951382

0.014

50.29

97.53

93.95

10898095216

72172816

0.0142

50.24

97.4

93.67

13575754962

89905662

0.0141

50.18

97.5

93.91

G2020_97_1
0
G2020_97_1
1
G2020_97_1
2
G2020_97_1
3
G2020_97_1
4
G2020_97_1
5
G2020_97_1
6
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Alignment Rates of 16 Samples
Uniquely

Multimapped

overall

mapped reads
14630044

reads %
892937

alignmen

(72.50%)

(4.42%)

95.18%

20179493

19814512

1189821

(74.21%)

(4.46%)

94.73%

26698979

20443988

1173106

(74.77%)

(4.29%)

93.89%

27341091

38568299

2213004

(75.48%)

(4.33%)

94.11%

51095665

17924575

1068032

(73.00%)

(4.35%)

92.50%

24552878

22244234

1297664

(75.31%

(4.39%)

95.03%

29535931

20104162

1162784

(74.90%)

(4.33%)

93.72%

26843089

19321199

1139763

(72.74%)

(4.29%)

94.30%

26561222

21397477

1208165

G2020_97_9

(74.28%)

(4.19%)

94.68%

28806650

G2020_97_1

23887711

1289011

0

(75.13%)

(4.05%)

92.91%

31794504

G2020_97_1

19276077

1041103

1

(75.83%

(4.10%)

93.84%

25419009

G2020_97_1

24307681

1342764

2

(75.39%)

(4.16%)

94.19%

32240455

G2020_97_1

13089575

832323

3

(72.13%)

(4.59%)

91.16%

18146829

G2020_97_1

18870168

1083474

4

(75.26%)

(4.32%)

93.62%

25074000

G2020_97_1

19086799

1078211

5

(75.97%)

(4.29%)

93.97%

25122814

G2020_97_1

23306911

1295109

6

(75.36%)

(4.19%)

93.17%

30926336

Sample ID
G2020_97_1
G2020_97_2
G2020_97_3
G2020_97_4
G2020_97_5
G2020_97_6
G2020_97_7
G2020_97_8
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Total number of reads

2 -∆∆ct values and PCR mean amplification efficiency
Gene

Biological

Mean

group

amplification

Symbol
Actb

Vgf

35M

2.029

Reference gene

NA

125M

20.50

125F

21.21

35M

1.871

38.01

1.84

0.88

35F

37.56

0.44

-1.18

125M

37.42

1.43

0.51

37.40

2.84

1.51

30.19

1.07

0.09

35F

28.91

1.56

0.64

125M

25.67

18.29

4.19

26.59

7.73

2.95

24.37

1.11

0.15

35F

23.91

1.05

0.07

125M

22.90

2.07

1.05

24.46

0.98

-0.03

25.64

1.02

0.03

35F

25.53

1.02

0.03

125M

26.83

0.34

-1.56

27.18

0.54

-0.90

27.36

1.03

0.04

35F

28.46

1.38

0.46

125M

30.03

0.14

-2.89

28.91

1.04

0.05

35M

2.030

35M

2.059

35M

2.021

125F
Gfap

20.89
20.72

125F
S100b

Log2FC

35F

125F
Oxt

Average2 -DDct

efficiency

125F
Bdnf

Mean Ct

35M

125F

1.994
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Rt1-m3

35M

2.01

27.30

1.00

0.00

35F

27.31

1.01

0.01

125M

26.36

1.42

0.50

27.23

1.56

0.65

24.14

1.04

0.05

35F

24.65

1.03

0.04

125M

24.77

0.49

-1.02

26.57

0.58

-0.79

30.50

1.43

0.52

35F

29.30

1.54

0.62

125M

27.90

4.73

2.24

29.50

1.46

0.55

27.03

1.01

0.02

35F

26.83

1.00

0.00

125M

25.65

1.99

1.00

26.88

1.38

0.46

125F
Rt1-a2

35M

2.05

125F
Sox11

35M

2.013

125F
Tapbp

35M

125F

2.05
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log2FC of selected genes from both RNA seq experiment and qPCR
experiment
RNAseq

RNA

gene

group

qPCR log2FC

log2FC

seqPvalue

qPCR pValue

Bdnf

125F/35F

2.817901538

0.984263987

0.001551122

0.23947

125M/35M

4.155206825

1.738971339

6.12E-20

0.0004

125F/35F

0.039966565

-1.068980529

7.60E-08

0.9655

125M/35M

-3.105318026

-1.623062134

1.45E-22

0.0086

125F/35F

0.329341778

-1.01208228

2.59E-10

0.95984

125M/35M

2.245921533

-0.886453264

0.000877808

0.0479

125F/35F

-1.148704698

-1.252147349

3.37E-37

0.23947

125M/35M

-1.589876022

-1.389930241

4.19E-22

0.0016

125F/35F

-0.056356178

0.690701624

7.12E-13

0.95984

125M/35M

1.058455043

0.858073399

0.0005149

0.0606

125F/35F

-1.426819397

0.90989956

0.001081636

0.30381

125M/35M

-1.030913993

0.668861778

0.004463699

0.0145

125F/35F

0.570521221

0.684368044

1.03E-21

0.23947

125M/35M

0.507008078

0.4689044

0.002663384

0.0145

125F/35F

0.434785665

0.783450541

8.85E-29

0.23947

125M/35M

0.986665774

0.74753682

4.24E-05

0.0016

Gfap
Sox11
S100b
Oxt
Rt1-a2
Rt1-m3
Tapbp
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List of qPCR primers (Qiagen)
Primer

Cat number

oxt

QT01809752

Vgf

QT00493556

bdnf

QT00375998

sox11

QT00381661

gfap

QT00195517

s100b

QT00184744

RT1-A2

QT00443240

RT1-M3

QT00194054

Tapbp

QT00189819
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